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ABSTRACT
Su, Hengjie. The University of Memphis. February 2020. In vitro and in vivo
evaluation and mechanical improvement of the electrospun chitosan membrane.
Major Professor: Dr. Joel D. Bumgardner.
Guided bone regeneration (GBR) membranes are used for providing barrier
function in guiding bone regeneration. Chitosan has been explored for making GBR
membranes since it is biocompatible and biodegradable. Our group developed
electrospun chitosan membranes (ESCM) using two novel post-spinning treatments;
triethylamine (TEA)/di-tert-butyl dicarbonate (tBOC) treatment and the butyrylanhydride (BA) treatment. These treatments prevented swelling and retained the
nanofibrous structure of the membranes in aqueous environments, and exhibited
physical properties, cell and tissue responses, and effective barrier function in vivo
that are promising for GBR applications.
The objectives of this research were to:
1. Further evaluate impact of TEA/tBOC-stabilized nanofiber structure of
electrospun membranes in fibroblast-osteoblast co-cultures.
2. Evaluate TEA/tBOC treated chitosan electrospun guided bone regeneration
membranes to augment bone healing in a grafted rodent calvarial defect
model as compared to a commercial collagen membrane.
3. Explore improving mechanical properties of the TEA/tBOC treated chitosan
membrane using elastin.
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In the first objective, only the TEA/tBOC treated membranes exhibited the
nanofibrous structure and the greatest pore volume as compared to traditional
Na2CO3 treated ESCM or chitosan films. All these three types of membranes showed
similar fibroblast and osteoblast proliferation capability. In a dual fibroblastosteoblast cell culture, the TEA/tBOC treated ESCMs were more effective in
promoting osteoblast mineralization. This result is significant in that it supports the
hypothesis that the nanofibrous structure leads to effective nutrient exchange between
the osteoblast and fibroblast growth environments leading to improved bone
formation.
In the second objective, rats with the chitosan membranes and the collagen
membrane all showed significant increases in the bone growth after both 3 and 8
weeks. The chitosan membrane groups showed significant more bone density than the
collagen membrane group, which might indicate that the chitosan membrane was
more effective in promoting bone mineralization than the collagen membrane.
In the third objective, chitosan added with elastin showed that the membrane with
increased ratio of elastin has increased mechanical strength, fiber diameters and
degradation ratio. In addition, all the chitosan-elastin membranes were compatible
with fibroblasts and osteoblasts.
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CHAPTER 1: INTRODUCTION
1.1 Imperceptible aggressive clinical problem
Periodontitis is one of the most common diseases of mankind and is also the
major cause of tooth loss in the adult population [1]. Periodontal disease increased by
57.3% from 1990 to 2010 most likely due to the increase in life expectancy in the
world [2]. In 2010, severe periodontitis was reported to be 6th most prevalent disease
with an overall 11.2% prevalence and affecting 743 million people in the world [2].
Periodontal disease is characterized by periodontal ligament loss and destruction of
surrounding alveolar bone which is caused by bacterial biofilm (dental plaque) that
accumulates on teeth adjacent to the gingiva (gums) [3,4]. The most frequent of all
forms of periodontal disease are plaque-induced gingivitis and periodontitis [5].
Based on the presence of the gingival inflammation, plaque-induced gingivitis does
not the connective tissue attachment and the underlying alveolar bone, but plaqueinduced periodontitis is characterized by formation of periodontal pockets, increased
probing depths and apical migration of the epithelial attachment onto the root surfaces
accompanied by loss of connective tissue and alveolar bone [5]. Smoking is one of the
behavioral factors that significantly increases the susceptibility and severity of
periodontal disease due to its modification of the complex interaction of oral cavity
bacterial infection and host response [3]. People with periodontal disease have 19%
increased risk of cardiovascular disease, and this risk increases to 44% among
individuals aged over 65 years [3].
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Currently, the periodontal treatments can cease the progression of periodontal
destruction through plaque control [5]. It generally involves scaling/root planting with
dental instruments or mechanical debridement that remove the calculus (mineralized
deposits) and bacterial biofilm from the root surfaces and short-term use of antiseptic
mouth washes and/or antibiotics to eliminate bacteria on and around the tooth surface.
In cases where there has been extensive periodontal ligament and alveolar bone loss,
surgical interventions involving bone grafts may be used to generate normal
periodontal supporting bone and prevent tooth loss [6]. In these treatments, a thin
membrane is used in guided bone regeneration (GBR) procedures that involve use of
these membranes to direct the formation of bone in the defect sites and act as barriers
to prevent the migration of fast proliferating soft tissues into the bone defect and the
graft [7]. Early in 1980s, experimental studies showed that placement of GBR
membranes had considerable positive effects on bone formation and these reported
effects were much better in comparison to no membrane placement between the
gingival tissue and the bone graft [6,8]. During the surgery, an occlusive GBR
membrane is placed into the defect site as a barrier to exclude the gingiva tissue
migrating into the lesion, to protect the regenerating bone tissues and graft materials
and to prevent formation of vertical deep crevices between the adjacent oral bone and
the tooth (Figure 1) [6,9,10]. Once the GBR membrane is implanted, typical healing
response occurs in which cells located in and around the surgical site adjacent to the
tooth /bone tissues migrate into the protected space and the graft materials and grow
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and differentiate into new supporting tissues including functional new bone,
periodontal ligament, and cementum [10].
Periodontal disease, if untreated or poorly managed, will lead to bone resorption
and loss of the native dentition. Dental implants have become a popular and
predictably successful therapy to replace native dentition lost to periodontal disease or
injury and is considered standard of care. Success of dental implants is due in part to
their ability to become well integrated into bone in a process called osseointegration.
Successful osseointegration requires sufficient alveolar bone height and volume to
accommodate and support the dental implant. GBR membranes are also employed
with bone graft materials to help regenerate lost alveolar bone prior to dental implant
placement surgery (Figure 2) [9,10].

Figure 1. The GBR membrane is applied for the repair of supporting alveolar bone.
a. vertical deep crevice in the mandible; b. the GBR membrane is placed between the
mucosal flap and the debrided bone defect; c. the membrane starts to degrade after 3
to 5 months while new bone forms and fills the defect; d. reconstructed functional
supporting alveolar bone [9].

Figure 2. The GBR membrane is applied for alveolar crest volume augmentation.
a. defecient alveolar ridge; b. membrane placed between the bone and soft tissues to
serve as scaffold for the bone graft and prevent soft tissue from filling the defect; c.
3

the membrane is shaped and stabilized to ideal alveolar contours; d. augmented
alveolar ridge after 5-6 months[9].
1.2 Current commercialized GBR membranes
Current membranes in clinical application are classified as non-absorbable, such
as expanded Polytetrafluoroethylene (ePTFE) membranes (e.g. Gore-Tex®, W.L.Gore
&Associates, US), and absorbable membranes, based on polyglactin (e.g. Vicryl®,
J&J Medical Device Company, US), polygycolic (PGA) and polylactic (PLA) acid
copolymers (e.g. Resolut Adapt®, W.L.Gore &Associates, US) and absorbable
collagen-based membranes (e.g. BioMend® and BioMend Extend®, Zimmer Biomet
Dental, US) [11,12]. However, non-absorbable membrane implantation requires
removal in a second surgery 4 to 6 weeks after implantation [13]. In contrast with
non-absorbable membrane, absorbable membranes can degrade during the healing
process and do not require another surgery procedure for removal. Therefore,
absorbable membranes have become more common and treatment of choice because
of their advantages in clinical operation.
Compared with non-absorbable ePTFE membranes, collagen membranes have an
enhanced ability to promote cell proliferation [14]. Although collagen membranes
have been widely used commercially as the main GBR membrane in clinical dentistry,
it was shown that they may be easily contaminated by bacteria, which results in
premature degradation and loss of barrier function and elongated wound healing time
[15]. A study from Paul et al. showed that collagen membranes became colonized by
bacteria in the oral cavity, leading to the early membrane degradation and can result in
limited to no healing of the wound after 6 months [16]. Antibiotics were added in the
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collagen membranes to overcome this shortcoming, but collagen membrane saturated
with metronidazole failed to have better results than the collagen membrane alone in
randomized clinical trials [17,18]. Thus, while these resorbable and non-resorbable
membranes have led to improvements in periodontal treatments and regeneration of
the alveolar bone, there is still a need to improve GBR membranes by overcoming
limitations of non-resorbable membranes and providing predictable degradation and
effective barrier function. An ideal membrane should maintain the barrier function
enough time for new bone formation [19]. In brief conclusion, the GBR membrane
should fulfill the characters of biocompatibility, resorbable, the ability to create space,
cell occlusive property, and easy handling [19].
1.3 Electrospun chitosan membranes
Electrospun chitosan membranes have been reported to overcome limitations of
current GBR membranes by providing predictable degradation and a nanofiber
structure that mimics the natural extracellular matrix (ECM).
Electrospinning is a method used for producing membranes with nano-scale
porous structure. The porous structure of high surface area is similar to ECM
structure. The ECM favors cell growth and provides a porous structure for
communication and nutrient exchange between osseous and epithelial tissue
compartments that is important for healing, while remaining cell occlusive. This
creates a bioactive osteoconductive compartment for the regenerating cells/tissues and
accelerates healing rather than simply acting as a passive barrier. Nanofibers also
provide a high surface area for potential drug loading and delivery.
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Electrospinning uses high voltage electrostatic forces to spin polymer solution
into nano fibers and then to the fibrous membrane. Basic apparatus of electrospinning
includes a spinneret, a fiber collector and a high-voltage power supply. A spinneret is
usually a needle tip connected to a syringe with viscous polymer solution. The
polymer solution is fed through the needle tip constantly at a steady slow rate under
the control of a syringe pump. A fiber collector is placed facing to the spinneret from
a certain distance and is gently rotating when collecting the fibers. When considering
the membrane application, various shape and forms of collector have been invented to
produce membranes with desired designs. High voltage power supply provides high
voltage/low current to create an electrostatic field across the spinneret and the
grounded metallic collector during the electrospinning process. Meanwhile, the
polymer solution pendent droplet at the needle tip is elongated into a conical shape by
the electrostatic repulsive force. The conical shape is also well known as Taylor cone
[10]. Once the electrostatic force exceeds the surface tension of the polymer droplet, a
charged jet is forced from the tip of the Taylor cone and then is stretched and whipped
to the collector in a series of nano fibers. Generally, the fiber size is highly influenced
by the applied voltage, polymer solution viscosity, distance between the fiber
collector and the spinneret, solution pumping rate, and even the room humidity.
Chitosan has shown great potential in the GBR application due to its
biocompatibility and biodegradability. Chitosan is a polysaccharide that derives from
crustacean shells, and was discovered in 1859 by Rouget [20]. He found that chitin,
which was the original form of chitosan, become soluble in organic acids after boiling
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in a very concentrated potassium hydroxide solution. This modified chitin was studied
by Hoppe-Seyler in 1894 and named as chitosan. The chitin polymer is composed
predominantly of N-acetyl glucosamines and is insoluble in aqueous solution [21].
Treating chitin with strong base removes the acetyl groups resulting in a co-polymer
of N-acetyl glucosamine and glucosamine. When more than 50% of the repeat units in
the polysaccharide are glucosamine, the polymer is called chitosan. The mole fraction
of glucosamines in the polymer is referred to as the degree of de-acetylation (DDA)
and may range for 50% to 100% DDA (or 100% glucosamine repeat units). Since this
biopolymer belongs to the alkali polysaccharide family, chitosan has bacteriostatic
power [22,23]. It has been demonstrated that two oral pathogens, actinobacillus
actinomycetemcomitans and streptococcus mutans, were inhibited at a chitosan
(91.5% DDA) concentration as low as 0.001% in an in vitro study [22,23]. Hence,
chitosan has an exclusive advantage in the application of the periodontal treatment.
Additionally, chitosan is easily processed into membranes, nanofibers, nanoparticles,
and sponges [22-24].
The chitosan electrospun membrane combines the advantages of chitosan,
biocompatibility and biodegradability, and the advantages of electrospun membranes,
with high surface area and high porosity, mimicking the ECM structure. Hence, it has
great potential in the GBR treatment. In a review by Xu et al., chitosan membranes
were compared with other three resorbable membranes, which were made of
polylactic acid, polglycolic acid, and lactide/glycolide copolymer [22]. The chitosan
membranes was more efficacy in helping cementum generation and bone cell
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proliferation. Besides, more regular arranged cementoblasts and osteoblasts along the
new bone surface were observed in the chitosan membrane group than the other
membranes. Research has also shown that electrospun chitosan membranes had
shown cell compatibility in vitro and in vivo and have great potential for drug loading
[25-28]. Shin et al. produced electrospun chitosan membranes and showed that the
membranes had cyto-compatibility with hepatic cells in vitro and were potentially
viable for use in tissue formation [25]. Norowski et al. produced a series of genipin
crosslinked membranes and showed cyto-compatibility with osteoblast cells,as well as
in vivo biocompatibility and effective functional degradation ratio [26,27]. Sangsanoh
et al. compared nerve cell growth on several membranes, demonstrating the improved
cyto-compatibility of electrospun chitosan membranes than poly(3-hydroxybutyrate)
and poly(3-hydroxybutyrate-co-3-hydroxyvalerate) electrospun fibers [28].
1.4 Post electrospinning treatment
It is common to use trifluoroacetic acid (TFA)/dichloromethane (DCM) solution
as the solvent of electrospinning chitosan solution, which generates extremely
hydrophilic TFA salts that induce the membrane swelling. Strategies using base or
sodium carbonate may remove TFA salts but result in loss of the nano-fibrous
structure of the electrospun membranes.
Research from Geng et al. reported using concentrated acetic acid as the main
solvent for successfully electrospinning chitosan into membranes [29]. This work has
not been replicated since it is difficult to get the chitosan dissolved in acetic acid to
have enough surface tension strength and viscosity for the electrospinning process
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[30]. On the other hand, chitosan dissolved in trifluoroacetic acid has the elastic and
viscous properties for easily being stretched into fibers that is required for
electrospinning [31]. Chitosan membranes made from trifluoroacetic acid need a post
electrospinning chemical treatment to neutralize/remove the residual strong acid in the
membranes. However, the trifluoroacetic acid salts (TFA salts) generated from the
solvent in chitosan membrane are extremely hydrophilic and can easily induce the
swelling and dissolution of the membrane fibers. The most widely used methods for
the neutralization of electrospun chitosan membranes is by soaking in highly saturated
NaOH or Na2CO3 solution. solution. Sangsanoh e t al. has explained the possible
neutralization principle with highly saturated NaOH or Na2CO3 solution and then
demonstrated that the 5 M Na2CO3 solution is more effective in keeping the fibrous
structure of the chitosan membrane than the 5 M NaOH solution [32]. In their theory,
excess Na2CO3 in the saturated solution drives the continuous neutralization reaction
toward the result of trifluoroacetic acid elimination, hence, to exclude the swelling.
They also indicated that the H2O molecules generated from NaOH neutralization
process may be the reason for the swelling of the chitosan membrane. This theory is
on the basis that the neutralization reaction happens extremely fast and the rapid rate
may shield the effect of the water solvent. The assumption being that by avoiding the
H2O molecules generated from the neutralization process, it would be possible to
avoid membrane swelling. In the reality evaluation, the fibers still swell leading to
loss of the nano fiber and structure. Other studies have tried to stabilize the fibers by
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crosslinking agents but success in maintaining the fiber structure has been limited [3336].
To overcome the challenge of removing spinning salts from the electrospun
chitosan without loss of nanofiber structure in physiological environments, two
innovative treatments were developed. These treatments are focused on eliminating
TFA salts that remain from the electrospinning process and not just neutralizing the
pH value from acid to mild neutral. Hydrophobic groups were attached to the surface
of the fibers to prevent swelling during treatments to remove TFA salts. One method
uses triethylamine (TEA) and di-tert-butyl dicarbonate (tBOC) to stabilize membranes
and retain the nano-fibrous structure (Figure 3). Triethylamine (TEA) in acetone was
used as the agent for dissolving the TFA salts since the salts are easily dissolved in the
TEA/acetone solution but did not cause swelling of the fibers. In addition, di-tertbutyl dicarbonate (t-BOC) was used to generate hydrophobic wrap around –OH
groups of the chitosan molecule. By blocking the –OH groups, the hydrophilic
character of the fibers was reduced thereby further reducing/minimizing swelling of
the chitosan nanofibers in the membrane. The other method uses fatty acid anhydride
to add hydrophobic acyl groups to nanofibers (Figure 4). The fatty acids were
attached to the hydroxyl groups on the chitosan and the fatty acid chains also created
a hydrophobic wrap to prevent swelling. Both TEA/tBOC and fatty acid anhydride
treated membranes retained nanofiber structure over 4 weeks in aqueous environment.
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Figure 3. The reaction principle of TEA/tBOC treatment.

Figure 4. The reaction principle of fatty acid anhydride treatment.
The TEA/tBOC treated chitosan membrane exhibited better mechanical suture
tearing strength than the commercial PLA membrane (GUIDOR, Sunstar), and similar
mechanical strength with the BioMend Extend (Biomet/Zimmer), a commercial
collagen membrane. In addition, both TEA/tBOC treated membrane and fatty acid
anhydride treated membranes exhibited promising biodegradation rate and
biocompatibility similar with the membrane treated by sodium carbonate. A pilot rat
study of 12 weeks was performed to verify that both TEA/tBOC treated and fatty acid
anhydride treated chitosan membrane had similar performance compared to a
commercial collagen membrane (BioMend Extend, Zimmer dental) and showed lower
inflammatory scores than the collagen membrane [37]. Bone growth was observed
11

along both chitosan membranes into the defect with a strong trend for more percent
bone growth with the chitosan membranes than the commercial collagen membrane at
both 3 and 12 weeks.
1.5 Aim
While these initial studies demonstrate the potential of the TEA/tBOC and fatty
acid modified electrospun chitosan membranes for GBR applications, further
evaluations are needed. The TEA/tBOC treated electrospun chitosan membrane was
compared with the traditional sodium carbonate treated electrospun chitosan
membrane and the chitosan solution cast film in the surface morphology, porosity
property, water contact angle, ash content and the endotoxin level. Besides, the
hydrolysis rate of the tBOC groups of the TEA/tBOC treated chitosan membrane was
examined. In these studies, an alternative dual cell culture was introduced to simulate
the clinical periodontal treatment, rather than the individual fibroblast and osteoblast
tests, where the membranes provided the barrier function and kept relative individual
growth environment for the fibroblasts and osteoblasts.
Additionally, to test the clinical properties of the chitosan membrane on bone
regeneration, a larger scale animal study was done on the basis of the previous pilot
animal study with the TEA/tBOC treated chitosan membrane and the BA treated
chitosan membrane. For better characterizing the membrane quality, the endotoxin
levels of the two-method treated chitosan membrane were checked before the animal
study. Fourty-eight male rats were equally divided for the TEA/tBOC treated
membrane groups of 3 weeks and 8 weeks, BA treated membrane groups of 3 weeks
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and 8 weeks, and collagen membrane groups of 3 weeks and 8 weeks. Both
histological and the microCT analyses were performed to further evaluate the
membrane characteristics and functions.
Though the TEA/tBOC treated chitosan membrane has already exhibited better
mechanical strength than one commercial PLA membrane, it still showed lower
strength than the commercial collagen membranes. The operational handle-ability was
one important factor for the availability and even success rate of the clinical
operations. In exploring methods to increase the mechanical strength of the
electrospun chitosan membrane, elastin was mixed with the chitosan solution at
different ratios before the electrospinning. Other than the mechanical strength, the
surface morphology, water contact angle, FTIR spectrum, protein concentration,
degradation ratio, and in vitro compatibility of the elastin chitosan membranes were
evaluated.
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CHAPTER 2: THE IN VITRO COMPARISON OF THE ELECTROSPUN
CHITOSAN MEMBRANES TREATED BY TWO POST-ELECTROSPINNING
TREATMENTS AND THE CHITOSAN CAST FILM
Abstract
Electrospun chitosan membranes have been tested for guided bone regeneration
(GBR). In previous studies, our group has invented a novel post-electrospinning
method to better keep the nanofibrous structure than the traditional sodium carbonate
treatment. Following the previous study, chitosan membranes treated by the
triethylamine (TEA)/acetone and di-tert-butyl dicarbonate (tBOC) were compared
with the traditional Na2CO3 treated chitosan membranes (Na2CO3-ESCM) and the
chitosan cast films (CM-film) in this study. The results showed that only the
TEA/tBOC treated chitosan membrane (TEA/tBOC-ESCM) retained nanofibrous
structure and had the most pore volume of the three types of membranes evaluated.
Twenty percent tBOC groups of the TEA/tBOC-ESCM gradually hydrolyze in the
aqueous environment at 37 ˚C in 21 days. The chitosan membranes made via solution
cast had the most hydrophobic surface and the Na2CO3-ESCM had the most
hydrophilic surface. The Na2CO3-ESCM showed more ash content (< 2%) than the
other two (< 0.5%). All the membranes showed extremely low endotoxin levels that
were under the FDA limitation. They showed no significant difference in the
fibroblast and osteoblast viability. The dual cell culture group with the TEA/tBOCESCM resulted in more deposited calcium than the other two membrane/film, which
might be due to the fibrous structure of the TEA/tBOC-ESCM allowing for more for
the nutrition and solution exchange in between the fibroblasts and osteoblasts.
Keywords: nanofibers, stabilization, guided bone regeneration.
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Introduction
Guided bone regeneration (GBR) membranes are used in dental applications to
prevent invasion of gingival tissues into the bone regenerating compartments. In
addition to the shielding/barrier function of the membranes, the interconnected
porosity and structure of the barrier membranes also play important roles in healing
by enabling exchange of nutrients and growth factors between the gingival and bone
compartments and mimicking extracellular matrix structure of newly forming tissues
[1-5]. Electrospinning is one method to make GBR membranes that mimics the native
nanofibrous ECM structure and provides an interconnected porosity to allow the
diffusion of nutrition, metabolites, and soluble factors between compartments that
support healing [6].
Chitosan is a natural polysaccharide that has been widely researched as a GBR
material due to its biocompatibility, homology to native ECM component hyaluronan,
degradability, and its ability to be electrospun [7]. However, electrospun chitosan
membranes can be highly susceptible to swelling and loss of nanofiber and
interconnected porous structure [7]. Our group has successfully developed a novel
post-electrospinning method that retains the nanofibrous structure electrospun
chitosan membranes [7]. The post-spinning modification involves first removing
acetate ions left over from the electrospinning process in the fibers using
triethanolamine (TEA) and then reacting di-tert-butyl dicarbonate (tBOC) with the
chitosan amines to create a hydrophobic wrap on the outside of the electrospun
chitosan fibers. We demonstrated that the TEA/tBOC process was able to prevent
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swelling and retain the nanofiber structure of the membranes in physiological
solutions whereas typical Na2CO3 treatment used to remove acetate ion salts resulted
in extensive swelling and loss of nanofiber structure [7]. These modified ESCM were
shown to be compatible with cultured cells, to degrade in vitro, to possess adequate
mechanical properties for GBR applications, to provide effective barrier function, and
to support bone healing in a rodent model [7].
The aim of this study was to further examine the impact of the retained nanofiber
morphology and porosity on the cell performance of the electrospun chitosan
membrane (ESCM) as compared with a Na2CO3 treated ESCM and a solid solution
cast chitosan membrane. The membrane surface morphology, porosity, water contact
angle, FTIR spectrum, ash content, endotoxin content, and in vitro cell compatibility
were evaluated using a novel dual cell culture method with fibroblasts and
osteoblasts. This dual culture model was introduced to simulate the clinical
application of periodontal treatment that isolates the fibroblasts and osteoblasts in two
relative individual compartments and growth environments.
Methods
Chitosan membrane and film preparation
Three types of chitosan-based membranes were prepared for this study; a]
electrospun chitosan membranes treated with TEA/tBOC (TEA/tBOC-ESCM), b]
electrospun chitosan membranes treated with Na2CO3 (Na2CO3-ESCM) and c]
solution cast chitosan membrane films (CM-films) treated with NaOH. The
electrospun membranes were spun at 26kV as described in previous studies using a
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71% DDA chitosan (primex, Iceland) dissolved at 5.5 (w/v)% in 7:3 (v/v)
trifluoroacetic acid (TFA, Fisher, US) and dichloromethane (DCM, Sigma Aldrich,
US). To make the TEA/tBOC-ESCM, membranes were first immersed in 10% (v/v)
TEA/acetone solution for 24 hours. After washing with acetone 3 times, membranes
were immersed in the 0.1 g/ml tBOC solution for 48 hours and then again washed
with acetone 3 times [7]. Membranes were dried between two pieces of nylon mesh
and under the heavy weight to exclude the moisture in air. To make the Na2CO3ESCM, electrospun membranes were immersed in 5 M Na2CO3 solution for 3 hours at
room temperature and then dried between two pieces of nylon mesh [8].
To prepare CM-films, a 2 % (w/v) chitosan (71% DDA) in 2% acetic acid
solution was prepared by stirring overnight. Twenty-eight-millimeters of chitosan
solution was pipetted into a petri dish (diameter = 8.5 cm) and allowed to dry for a
few days at ambient conditions. For the neutralization, 2 M NaOH/DI H2O solution
was pipetted into the petri dish to immerse films for 1 hour. CM-film was rinsed with
DI H2O for 30 minutes 3 to 5 times to remove excess NaOH and then dried in air at
room temperature.
Surface morphology
SEM (EVO HD15, Carl Zeiss AG, Germany) was used for observing the surface
morphology of both types of ESCMs and the CM-film. Materials were attached to
SEM stubs and coated with 8 nm gold-palladium and observed from 2500X to 6000X
[7]. Fiber diameters of three samples per group were measured at the same time.
Porosity
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The porosity of the ESCM and the CM-film were evaluated via porosimeter
(Pascal 140 Mercury Porosimeter, Thermo Fisher Scientific, US) with the pore size
measuring range of 116 to 3.8 µm. Measurements (n=3/membrane) were made on test
samples of equivalent mass.
Water contact angle
Water contact angle was used for evaluating the surface hydrophobic/hydrophilic
character. The contact angle of water drops contacting the membranes surface (n = 3)
was recorded by the VCA optima measurement machine (AST products, INC).
Fourier transform infrared spectroscopy (FTIR)
FTIR was used to characterize the chemical composition of the membranes.
Specifically, FTIR was used to verify removal of TFA salts, reaction of the tBOC for
the TEA/tBOC-ESCM, and the presence of carbonate for the Na2CO3-ESCM. FTIR
spectra were collected using a Nicolet 380 FTIR spectrometer (Thermo Electron
Corporation). Membranes were scanned from 500 cm-1 to 4000 cm-1 for repeated 32
times.
TBOC hydrolysis
A tBOC hydrolysis experiment was performed for exploring whether the tBOC
groups gradually dissolved in the aqueous environment, and hence increased the
hydrophilic property of the TEA/tBOC-ESCM. TEA/tBOC-ESCMs (n = 1) were
dissolved in D2O with the ratio of 30 mg membrane/1.5 ml D2O for time points of day
1, 2, 3, 5, 8, 15 and 21 at 37 ˚C and 70 ˚C. A JEOL NMR 400MHz (JEOL, US) was
used for analyzing the deuterated supernatant solution. The relative intensity of
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chitosan-tBOC peaks (1.3ppm) and t-butanol (tBuOH) peaks (1.1ppm) were
calculated against acetyl peak (1.9ppm) in the dissolved chitosan solution as
indicators of tBOC hydrolysis.
Ash content
Ash content of the test membranes was measured as an indicator of residual
mineral from the original chitosan powder or as a result of manufacture of ESCM or
the CM-film. Constant weight crucibles were used as the container and their weight
was measured after repeatedly placing the crucible in the 550 ± 20 °C oven for 2
hours and cooled down in a desiccator to the room temperature, recorded as W0.
Chitosan powder/membranes (n = 3/group) in crucibles were weighed as W1. Another
similar heating process of crucibles and chitosan contents was repeated every 3 hours
with the same cooling time until the constant weight W2 was achieved. The ash
percentages were calculated by the equation: ash% = [(W2-W0)/(W1-W0)] × 100. The
accuracy was limited to 0.001 g.
Endotoxin
Endotoxin of the chitosan test membranes was tested by the Pierce LAL
chromogenic endotoxin quantitation kit (Thermo scientific, US). Disc-shaped chitosan
membrane specimens (diameter = 1.5 cm) were ethylene oxide gas sterilized for 24
hours at ambient temperature (Anprolene AN 74j, Anderson Products, US). An
additional 2 hours venting cycle after gas sterilization was applied for degassing
process. Sterilized test ESCM and CM-films samples (n = 3) were soaked in pyrogenfree water at the ratio of 1:100 (µg sample/µl water) and incubated with continuous
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shaking for 24 hours at 50 ˚C [9]. Bacterial endotoxin in the extract solution activated
the proenzyme in the modified Limulus Amebocyte Lysate (LAL). The activated
proenzyme catalyzed the p-Nitroailine (pNA) splitting from the colorless substrate
that was proportional to the sample endotoxin concentration. A standard curve of
Escherichia coli endotoxin was used for calculating the sample endotoxin. The
amount of endotoxin in micrograms was normalized to mass.
In vitro evaluation
Culture media was prepared by mixing α-MEM-media (Corning, Cellgro) with
5mM β-glycerophosphate, 50 µg/ml ascorbic acid, 10 nM dexamethasone, 10% fetal
bovine serum (FBS), 500 I.U. /ml penicillin, 500 μg/ml streptomycin, and 25 μg/ml
amphotericin-B. Test membranes were evaluated for growth of fibroblast and
osteoblast cells separately and in co-cultures using transwell system.
Fibroblast cell culture
Sterilized disc-shaped chitosan membrane specimens were placed in 24-well
plates topped with silicon rings (outer diameter = 15.9 mm; inner diameter = 9.4 mm)
for sealing membranes from the open well area and rinsed in culture media for 24
hours. Each well with membrane/film was seeded with 104 NIH 3T3 fibroblasts. NIH
3T3 cells were grown for 1, 3, 7 days on the CM-film and membranes (n =
4/membrane or film/time point). Cell Titer GloTM luminescent cell viability assasy
(Promega, Madison, WI, US) was used for evaluating cell proliferation. Alexa Fluor®
488 phalloidin (Life technologies, US) and NucBlue® Fixed Cell Stain
ReadyProbesTM reagent (Life technologies, US) were used for observing cell
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morphology (n = 1/membrane or film/time point).
Osteoblast cell culture
Disc-shaped chitosan membranes specimens placed in24-well plates underwent
similar procedures to secure the membrane in the well and rinsing with cell culture
media for 24 hours. Each well with membrane/film was then seeded with 104 MC 3T3
cells. MC3T3 cells (osteoblasts) growth and mineralization for 4, 7, 14, 21 days on
the CM-film and membranes (n = 4/membrane or film/time point). Cell Titer GloTM
luminescent cell viability assasy (Promega, Madison, WI, US) was used for the cell
number evaluation.
Fibroblast and Osteoblast Co-culture
Initially, each well with no membrane of the 24-well plate was seeded with 2×104
MC3T3 cells/sample. After overnight growth, FalconTM cell culture inserts (Corning,
US) were placed into each well with membrane/film. Disc-shaped chitosan specimens
(diameter = 6 mm) were put in the cell culture insert and immersed in culture media
overnight. Then 104 NIH 3T3 cells/sample were seeded on the membranes in the cell
culture insert (Figure 1). The co-culture groups were described in the Table 1. Cell
Titer GloTM luminescent cell viability assay (Promega, Madison, WI, US) was used
for the NIH 3T3 and MC 3T3 cell proliferation evaluation (n = 3/membrane or
film/time point). QuantiChromTM Alkaline Phosphatase Assay Kit (BioAssay
Systems) and Calcium Deposition Assay for in vitro Osteogenesis (Pointe Scientific,
Inc.) were used for evaluating the MC3T3 cell mineralization (n = 3/membrane or
film/time point). Immunostaining was performed using anti-osteocalcin (BGLAP
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Picoband™ antibody, Boster Biological Technology, US) combined with the Donkey
anti-rabbit IgG ReadyProbes™ secondary antibody conjugated to Alexa Fluor 488
(ThermoFisher Scientific, US) and ProLong™ Diamond Antifade Mountant with
DAPI (ThermoFisher Scientific, US) in order to evaluate cell mineralization (n =
1/membrane or film/time point). The immune-stained slides were observed by the
Nikon eclipse Ti microscope (Nikon, US) and the NIS elements viewer (Nikon, US)
under the same brightness and contrast condition.
Table 1. Co-culture groups description.
Group
Cell
culture
insert

Well plate
bottom

TEA/tBOCESCM
NIH 3T3
cells on the
TEA/tBOCESCM (FbrTtB)
MC 3T3
(Ost-TtB)

Na2CO3ESCM
NIH 3T3
cells on the
Na2CO3 ESCM (FbrNaC)
MC 3T3
(Ost-NaC)

CM-Film

Control 1

Control 2

NIH 3T3
cells on the
CM-film
(Fbr-CMf)

No
membrane
NIH 3T3
cells only
(Fbr-trw)
MC 3T3
(Ost-trw)

No cell
(No)

MC 3T3
(Ost-CMf)

MC 3T3
(Ost-No)

Statistical analysis
The results of the fiber diameter, water contact angle and ash content were
analyzed by the one-way Analysis of variance (ANOVA) at the 0.05 level of
significance. The cell culture results were analyzed by the two-way ANOVA (α =
0.05). As appropriate, Tukey’s post-hoc tests were used to distinguish significantly
different groups.
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Figure 1. Diagram of co-culture conditions.
The MC3T3 cells were seeded on the bottom of wells. After one-night growth, cell
culture inserts topped with samples were put in wells. Then the NIH3T3 were seeded
on the membrane/film samples.
Results and discussion
Scanning electron microscopy (SEM)
The SEM graphs of the ESCM and CM-films are shown in Figure 2. The nontreated ESCM membrane showed nanoscale fibrous structure with average fiber
diameter of 219.03 ± 92.95 nm. The TEA/tBOC-ESCM retained the nanofibrous
structure with the fiber diameters of 237.79 ± 105.76 nm. There was no significant
difference of the fiber diameters in between the non-treated membrane and the
TEA/tBOC-ESCM (p < 0.05). The Na2CO3-ESCM exhibited swelling and almost
complete loss of fibrous structure after the Na2CO3 treatment. The fibers were
indistinguishable and could not be quantified. The CM-film exhibited a smooth
uniform surface without any fiber structure.
In one previous study, the non-treated electrospun chitosan membranes made
under the same condition had the fiber diameters of 228 ± 116 nm, which was
coincident with this study [8]. In another previous study, the TEA/tBOC-ESCM had
the fiber diameters of 388 ± 132 nm [7]. The decreased fiber dimeters of the
TEA/tBOC-ESCM in this study might be due to the differential details of the
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TEA/tBOC treatment, such as the change of environment temperature, lower
environment humidity, and shorter time interval that the membranes were exposed to
air during the TEA/tBOC treatment. Further study will be needed to explore more to
evaluate the effects that these conditions have on

fiber diameter variation. However,

the fiber diameters of the TEA/tBOC-ESCM in the two studies were both close to
natural ECM fiber diameters, which range from 50 to 500 nm [10]. Compared with
the TEA/tBOC-ESCM, the Na2CO3-ESCM has almost lost all the fibrous structure,
which was also observed in the previous studies [8,11].

Figure 2. SEM images of the (A) non-treated chitosan electrospun membrane, (B)
TEA/tBOC-ESCM, (C) Na2CO3-ESCM, and (D) the CM-film.
The TEA/tBOC-ESCM exhibited similar nanofiber morphology and diameters as the
as-spun membranes, whereas the Na2CO3-ESCM show significant fiber swelling and
loss of nanofiber morphology. The CM-film exhibited a smooth surface and no
fibrous structure.
Porosity
The median pore sizes of the membranes and the pore volume are shown in Table
2. The TEA/tBOC-ESCM showed significantly more pore volume than the other two,
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which correlated with SEM observations. The Na2CO3-ESCM had some pores that
were significantly more than the CM-film, which was nearly fully solid.
Electrospun membranes with densely packed matrices that formed during the
electrospinning process usually had small enough pore sizes to prevent the infiltration
of cells into the bulk [12]. At the same time, better porosity of the electrospun
membranes indicated better porous structure for nutrients and metabolic waste
exchange between the scaffold and tissue environment, as well as more surface area
for local and sustained delivery of biochemical signals to the seeded cells [13]. The
TEA/tBOC-ESCM with more pore volume than the other two type samples should
have better ability for nutrient and metabolic waste exchange. Researchers have also
explored the relationship between pore size and cell proliferation, although
conclusions vary. O’Brien et al. demonstrated that cell adhesion linearly increased
with increasing surface area and decreasing pore size diameters ranging from 95.5 to
150.5 μm [14,15]. Bhattarai et al. reported that the electrospun scaffolds with more
than 80% porosity, 8 μm median pore size and 5 m2/g pore area showed feasible
accommodation for cell growth and migration [16]. Another study suggested that the
pore diameter ranges from 25 to 100 μm were adequate for cell migration and growth
[17]. In this study, all the three type membranes had the median pore sizes fall in the
lower range of these previous studies (11.4 to 15.1 μm). However, the parameter of
total pore volume might be more significant in affecting cell performance.
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Table 2. water contact angle and porosity result. §, ×, *, and # denoted significant
difference from the CM-film.
CM-film
Na2CO3-ESCM
TEA/tBOC-ESCM
median pore size
11.4
12.2
15.1
(μm)
total pore volume
0.1 ±0.2
32.4 ±47.1§
461.0 ±96.6×
(mm3/g)
contact angle
96.2 ±2.4
76.0 ±10.8*
87.4 ±9.0#
(degree)
Water contact angle
Higher water contact angle indicates more hydrophobic surface. The CM-film
had significantly higher water contact angle than the TEA/tBOC-ESCM, and the
TEA/tBOC-ESCM had significantly higher water contact angle than the Na2CO3ESCM (Table 2). Hence, the Na2CO3-ESCM had the most hydrophilic surface, and
the CM-film was the most hydrophobic.
These results are in agreement with previous studies showing that the
TEA/tBOC-ESCM was more hydrophobic than the Na2CO3-ESCM [7]. This is
reasonable since the tBOC group increase the hydrophobic property to the chitosan
membrane. In Leceta’s study, the water contact angle of CM-films was around 105
degrees, which was similar to this study [18]. The water contact angle of the TFA
dissolved electrospun chitosan membrane in the Shan’s study was only 61.5 ± 1.0
degrees [19]. However, this study did not report post-electrospinning treatment details
and in fact the non-treated electrospun chitosan membrane dissolved quickly when in
contact water. In our previous study, the water contact angle of TEA/tBOC-ESCM
was 119.4 ± 14 degrees and the angle of Na2CO3-ESCM was 95.9 ± 10.8 degrees,
which showed more hydrophobic than this study [7]. The decreased water contact
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angle of this study might be due to the differentiate factors during the process. TFA
dissolved the chitosan into small molecules might increase the hydrophilicity of the
electrospun chitosan membranes. According to this assumption, it is reasonable that
the CM-film showed more hydrophobicity than the chitosan electrospun membranes
since TFA may dissolve more chitosan than acetic acid. Additionally, the solid
structure of the cast film may hold the water better than the porous structure of the
TEA/tBOC-ESCM. More studies will be needed to prove this assumption.
Fourier transform infrared spectroscopy (FTIR)
The peaks at 720 (C–F), 802 (C–F) and 837 (C–F) cm−1 related to TFA salt,
which disappeared after both the TEA/tBOC treatment and the Na2CO3 treatment
(Figure 3), indicating that these two treatments both effectively removed the TFA salts
from the electrospun chitosan membranes. The CM-film also showed no peak at these
three positions, which was expected since acetic acid was used as the solvent instead
of TFAfor the CM-film.
In the previous study, peaks at 1688 cm−1 (C=O stretch), 1529 cm−1 (CO–NH2
bend), 1370 cm−1 (C–H bend) and 2980 cm−1 (C–H stretch) associated with the
tBOC group showed significant increase, which indicated the existence of the tBOC
group [7]. However, there was no significant increase of these peaks showed in this
TEA/tBOC-ESCM spectrum compared with the spectra of Na2CO3-ESCM and the
CM-film. This might relate to differences in the tBOC reaction time, which was
shorter in this study and hence have not formed as many tBOC groups on the
membrane surface. Further study will be needed to validate this assumption.
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Figure 3. The FTIR spectra of (A) the TEA/tBOC-ESCM, (B) the Na2CO3-ESCM,
(C) the CM-film and (D) the non-treated electrospun chitosan membrane.
The transmittance peaks related to TFA salts of the non-treated electrospun chitosan
membrane at 720 (C–F), 802 (C–F) and 837 (C–F) cm−1 disappeared after the
TEA/tBOC treatment (↑).
TBOC hydrolysis
The tBOC hydrolysis results showed that the chitosan-tBOC peak intensity
decreased at both the 37 ˚C and 70 ˚C after days, indicating that the tBOC was
hydrolyzed gradually with time in the D2O (Figure 4). This was coincident with the
result that the tBuOH peaks increased at 37 ˚C after days, indicating that the tBuOH,
which was the tBOC hydrolysis product, increased in the dissolved chitosan solution
after days. The intensity of chitosan-tBOC peaks at 37 ˚C were higher than the peaks
of 70 ˚C at the same time points, indicating that the tBOC degraded more at higher
temperatures.
The tBOC group was stable at room temperature, so that the fibers maintained
their structure [7]. At 37 ˚C, the tBOC group slowly degraded in the aqueous
environment, which indicated that the tBOC group degraded from the membrane
surface at body temperature. Small amounts of tBuOH produced from the hydrolysis
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would not be anticipated to have toxic effects and this molecule is not classified as a
human carcinogen [20]. It has also been identified in human breast milk and is known
to be slowly eliminated from the blood [21,22]. The chitosan-tBOC bond degraded
more at 70 ˚C than at 37 ˚C indicated that the hydrolysis rate was temperature
dependent. The hydrolysis rate in the D2O environment might not be the same with
the hydrolysis rate in the body, where proteins and other plasma components are
present.

Further in vivo studies would be needed to determine if hydrolysis rate in

the body is similar to these studies. Combined with the cell culture results, the tBOC
group did not appear to have adverse effect on cell growth. Besides, in the previous
cell culture study (data not shown), there was a jump proliferation after 7 days, which
might be related to the tBOC release of the chitosan membrane. The mighty
relationship of the tBOC releasing rate and the cell proliferation ratio should be
checked in the future.

Figure 4. The tBOC hydrolysis result.
The relative peak intensity of the chitosan-tBOC gradually decreased at 37 ˚C and 70
˚C when the TEA/tBOC-ESCM was immersed in D2O. The peak intensity of the
tBuOH gradually increased at the same time.
Ash content
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The results showed that there was no significant difference in ash content
between the cast film, TEA/tBOC-ESCM, and chitosan powder groups (Figure 5).
The ash contents of these samples were less than 0.5%. The Na2CO3-ESCM had less
than 2% ash content, which was significantly higher than the other groups.
The results indicated that the ash content did not increased during the process of
electrospinning. The significantly higher ash content of the Na2CO3-ESCM might be
due to the Na2CO3 residue in or on the membrane after washing by the high
concentrated Na2CO3 solution. Though the following step washed the membrane by
water for 3 times, residual Na2CO3 might not be totally washed off. Compared with
other studies, the ash contents of the chitosan powders were generally less than 2%
[23-27]. Hence, the ash contents of this study were within range of other chitosan
materials.

Figure 5. The ash content results of the cast film, TEA/tBOC-ESCM, Na2CO3-ESCM
and the chitosan powder.
The ash content of the Na2CO3-ESCM was significantly higher than the other groups.
* denoted the significant difference from other groups.
Endotoxin
The results showed that the endotoxin concentrations of the membranes were
under the kit test limit, which was 0.1 EU/ml. According to the 1:100 (w/v) ratio of
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the sample weight to water volume, the test limit of the endotoxin kit was 10 EU/g
(sample weight). Hence, the endotoxin contents in all the membranes were less than
10 EU/g.
The FDA guidance for pyrogen and endotoxin testing recommended that the
endotoxin limit for the cardiovascular system and lymphatic system directly or
indirectly contact medical products was 0.5 EU/ml or 20 EU/device [28]. The 14 mm
diameter membrane/film samples that were used in the previous rat calvarial defect
study were approximately 0.005 to 0.01 g. Hence, the endotoxin levels of all the
membranes were under FDA limit.
In vitro evaluation
Results of the growth study showed that both the NIH3T3 fibroblasts and the
MC3T3 osteoblasts grew and significantly increased (p < 0.05) in number over the 7
and 21 days of culture respectively on all three types of membranes (Figure 6). There
was no significant difference between three types of membranes on the growth of
either the fibroblasts or osteoblast cells. The fluorescent stain graphs (Figure 7) of the
NIH3T3 cells showed that the cells spread on the TEA/tBOC-ESCM and on the CMfilm after 3 days. The cells on the Na2CO3-ESCM did not spread after 7 days might be
due to either the porosity difference or residual Na2CO3. Future studies will be
needed.
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Figure 6. The (A) NIH3T3 and (B) MC3T3 cell proliferation results on the chitosan
membranes and the cast film.
The NIH3T3 cells on all the samples significantly increased in 7 days. The MC3T3
cells significantly increased after 21 days. There was no significant difference in
between the sample groups. * and + denoted the significant difference from day 1. #
denoted the significant difference from day 3 and day 7.

Figure 7. The NIH 3T3 cells on the membranes at day 1, 3 and 7 were stained by the
Alexa Fluor® 488 phalloidin and NucBlue® Fixed Cell Stain ReadyProbesTM reagent.
In the co-culture, the NIH3T3 cells and MC3T3 cells also showed significant
increases in cell growth over the 28 days of culture (Figure 8). The NIH3T3 cells
showed no significant difference of cell proliferation in between the membrane types.
For the MC3T3 cells, the cell proliferation on the CM-film was significantly lower
than the other groups (p < 0.05). The ALP concentration normalized to the DNA
amount showed significant increases in all groups after 14 and 28 days. Osteoblasts in
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co-culture with the fibroblasts on the CM-film showed the highest ALP activity of the
test groups on day 14 and 28, while osteoblasts in co-culture with fibroblasts on the
ESCM’s tended to have ALP activities that were either comparable or lower than
osteoblasts cultured alone or in control co-culture. The calcium concentration also
showed significant increase in all groups after 14 and 28 days. Among the groups, the
Ost-TtB and the OST-trw groups showed significant higher calcium concentration
than the Ost-CMf and Ost-No groups, and the Ost-NaC group showed significant
lower calcium concentration than the other groups. The fluorescent stains graphs of
the osteocalcin (Figure 9) showed that the cells produced increased osteocalcin after
14 days, which is another indicator confirming increased osteogenic activity indicated
by

ALP and calcium deposition.
In the both individual and dual cell culture results, both the NIH3T3 and MC3T3

cells showed significant cell proliferation after days, which indicated that all the
membranes were cell compatible. In the previous study, Saos-2 osteosarcoma cells
showed significant proliferation after 5 days on both the TEA/tBOC-ESCM and the
Na2CO3-ESCM [7]. Hence, it could be concluded that the electrospun chitosan
membranes and the cast film showed cell compatibility with both fibroblasts and
osteoblasts. It was noted that the cells seeded on the membranes showed no
significant difference in cell growth between sample groups in the both individual
cultures and the co-culture systems. Besides, the morphology of the cells was not
particularly different on the different membranes, which might have implications of
how the cells elaborate matrix and support healing of tissues. Hence, though the
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TEA/tBOC-ESCM still kept porous structure, it might have similar cell adhesion and
proliferation properties compared with the other two.
The group with the TEA/tBOC treated chitosan electrospun membrane showed
more calcium concentration than the no NIH3T3 cell control group, which might
indicate that the TEA/tBOC-ESCM promotes cell mineralization. Since the
TEA/tBOC-ESCM was the only membrane type that has preserved the fibrous
structure, it could be considered that the group with the nanostructure membrane
showed more calcium deposition. This might be due to the better nutrient and cell
signal communication provided by the porous electrospun membrane in between the
NIH3T3 cells and the MC3T3 cells. This hypothesis is supported by the results that
the no membrane/film OST-TRW groups also showed higher calcium deposition than
the no NIH3T3 cell control group, which indicated that the existence of the NIH3T3
cells helped promote calcium deposition. The Ost-NaC and the Ost-CMf groups had
either lower or similar calcium deposition than the no NIH3T3 cell group, which
indicated that the membranes with no fibrous structure provide minimal
communication in between the NIH3T3 cells and the MC3T3 cells and hence did not
promote the calcium deposition. In Yang’s study, MC3T3 cells showed more
mineralization ability on the fibrous membrane with more chitosan than on the fibrous
membrane with more PCL, which indicated that chitosan could promote the cell
mineralization itself beyond the porous structure [c1]. In this study, the MC3T3 cells
were not directly in contact with the chitosan membranes, which might be the reason
that chitosan has not shown significant promotion on cell mineralization.
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Figure 8. The dual cell culture results of (A) the top NIH3T3 cell proliferation in the
cell culture inserts, (B) the bottom MC3T3 cell proliferation on the well bottoms, (C)
the ALP generation of the MC3T3 cells and (D) the calcium deposit of the MC3T3
cells at each time points. (A) #, * and + denoted the significant difference from day 4.
(B) * and + denoted the significant difference from day 4 and day 7. # denoted the
significant difference of the Ost-CMf from other groups. (C) * and + denoted the
significant difference from day 4 and day 7. $ and # denoted the significant difference
from the Ost-NaC, OST-TRW and Ost-No groups. (D) * and + denoted the significant
difference from day 7. # and $ denoted the significant difference from the Ost-CMf
and Ost-No groups.
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Figure 9. The fluorescent graphs of the anti-osteocalcin stained MC3T3 cells at day 4,
7, 14 and 28. The osteocalcin increased from day 4 to day 28.
In conclusion, the TEA/tBOC-ESCM preserved the nanofibrous and highly
porous structure when the Na2CO3-ESCM did not and the CM-film did not have any
fibrous structure and lacked porosity. Hence, the TEA/tBOC-ESCM had more pore
volume than the other two. The CM-film showed more hydrophobic than the other
two electrospun membranes, and the TEA/tBOC-ESCM showed more hydrophobic
than the Na2CO3-ESCM. The FTIR spectra showed the TFA salts were eliminated
after the TEA/tBOC treatment and the Na2CO3 treatment. The tBOC groups wrapped
the TEA/tBOC-ESCM slowly degraded at 37 ˚C. The ash contents of all the
membranes were under the 0.5% except the Na2CO3-ESCM, which was under the 2%.
All the membrane/film had extremely low endotoxin concentrations, which were
considered suitable for the FDA requirement. The in vitro evaluation showed that all
the membranes were osteoblast and fibroblast compatible. The TEA/tBOC-ESCM
showed more deposited calcium amount than the other two membrane/film. The more
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deposited calcium amount indicated the faster mineralization with the TEA/tBOCESCM membrane. In the clinical treatment, faster mineralization indicated faster bone
formation. Hence, the TEA/tBOC membrane might shorten the wound healing time in
the clinical treatment.
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CHAPTER 3: A COMPARISON OF ELECTROSPUN CHITOSAN
MEMBRANE IN TWO TREATMENTS AND COLLAGEN MEMBRANE IN
IN VIVO STUDY
Abstract
Background: Electrospun chitosan membranes subjected to post-spinning
processes using either triethylamine/tert-butyloxycarbonyl (TEA/tBOC) or butyrylanhydride (BA) modifications to maintain nanofiber structure have exhibited potential
for use in guided bone regeneration applications. The aim of this study was to
evaluate ability of the modified membranes to support healing of bone-grafted defects
as compared to a commercial collagen membrane.
Method: TEA/tBOC treated and BA treated chitosan membranes were
characterized for fiber morphology by electron microscopy, residual trifluoroacetic
acid by 19F NMR and endotoxin level using the endotoxin quantitation kit (Thermo
scientific, US). Then chitosan membranes were cut into 12 mm diameter disks. An 8
mm calvarial defect was created in each of 48 male rats and then filled with Bio-Oss
(Geistlich, US) bone graft. The grafted defects were covered with either (1)
TEA/tBOC treated chitosan membrane (2) BA treated chitosan membrane or (3) the
control BioMend Extend (Zimmer dental, US) collagen membrane. After 3 and 8
weeks, the rats were euthanized and calvaria was retrieved for microCT and
histological analyses (n=8/group/time points).
Results: Results showed that both TEA/tBOC treated and BA treated membranes
exhibited nano-fibrous structure, no TFA salt residue and low endotoxin levels. All
membranes supported increased bone growth from 3 weeks to 8 weeks. There was no
significant difference in bone growth among the membrane types. However,
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TEA/tBOC treated and BA treated chitosan membranes both showed significantly
higher bone density than BioMend Extend collagen membrane at both time points (p
= 0.0002).
Conclusions: Chitosan membranes showed better bone density promotion than
the collagen membrane and hence could better promoted the bone mineralization in
the clinical treatment.
Keywords: chitosan, electrospinning, rat calvaria, guided bone regeneration.
Introduction
Guided bone regeneration (GBR) membranes are widely used in patients with
cranio-maxillofacial injuries, periodontal disease, and/or undergoing implant
procedures to restore masticatory function, speech, and aesthetics [1]. They are
applied to direct the formation of bone in the deficient sites by acting as barriers that
prevent migration of soft tissues into the bone graft site. Commercially used GBR
membranes are commonly made of polylactide and polyglycolide (eg. Atrisorb®, and
Resolut LT®), and collagen (e.g. Bio-Gide®, BioMend Extend®, and Cytoplast®
RTM) [1]. However, these membranes have several shortcomings, including poor
mechanical handling properties, the collagen membranes have unpredictable
degradation that may not meet the healing time frame of 4 to 6 months, and the
polylactide membranes have acidic degradation products that reduce bone
regeneration, often leading to additional surgical interventions and longer treatment
times [2-5]. Hence, there is a need to improve GBR materials to support bone
regeneration and provide effective barrier function, strong handling characteristics for
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securing membranes in place, and predictable degradation rates with non-toxic
degradation products.
Research studies have examined chitosan, a naturally derived polysaccharide, for
guided tissue regeneration, because it is biocompatible, biodegradable, non-toxic and
has been widely used in tissue scaffolds [6, 7]. Electrospun chitosan membranes have
been explored as an alternative clinical choice to GBR membranes since the nanoscale fibers of the chitosan membranes could structurally mimic the natural
extracellular matrix. Recent studies have reported promising degradation, both in vitro
and in vivo biocompatibility, and barrier function of novel electrospun chitosan
membranes [8-10]. These membranes have been modified using two post-spinning
processes that serve to eliminate residual electrospinning salts that may be toxic and
improve retention and stability of the electrospun nanofiber structure [9, 10]. The
retention of nanofiber structure would allow for nutrient exchange and
communication between cells in connective tissue and bone compartments, and mimic
native extracellular fiber network. Other post-spinning treatment methods, like the use
of sodium carbonate or basic solutions, have been used to remove residual salts, but
are not effective in retaining the nano-fibrous structure of the electrospun membranes
[8]. One possible post-spinning treatment with Triethylamine (TEA) has been used to
remove the trifluoroacetic acid (TFA) salt formed during spinning process and the
tert-butyloxycarbonyl (tBOC) group was attached to the chitosan amino groups on the
outside of the fibers to create a hydrophobic wrap to reduce fiber swelling [10]. An
alternative treatment with butyryl anhydride (BA) has been used to attach a small
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chain fatty acid to the hydroxyl groups on the chitosan fiber surface, also creating a
hydrophobic wrap that maintained nano-fibrous structure during subsequent steps to
remove the TFA salts using water [9]. In an earlier study, TEA/tBOC treated chitosan
membrane showed better mechanical suture tearing strength than a commercial PLA
membrane (GUIDOR, Sunstar), and similar mechanical strength with a commercial
collagen membrane (Biomet, Zimmer) [10]. BA treated chitosan membranes showed
better tensile strength as compared to the commercial PLA membrane (GUIDOR,
Sunstar) [9]. A pilot rat study demonstrated that the TEA/tBOC treated and BA treated
chitosan membranes had similar performance in supporting new bone formation at 12
weeks in an un-grafted site when compared with a commercial collagen membrane
(BioMend Extend, Zimmer dental) [9, 10]. Bone growth was observed along
TEA/tBOC treated and BA treated chitosan membranes into the defect with a strong
trend for more percent bone growth with the chitosan membranes than the commercial
collagen membrane at 12 weeks [9,10]. In addition, TEA/tBOC treated and BA
treated membranes showed promising in vitro biodegradation rate and
biocompatibility similar with membranes treated with sodium carbonate [9, 10].
The main aim of this study was to evaluate and compare the ability of the
TEA/tBOC and BA membranes to promote bone regeneration in a bone-grafted site as
compared to a commercial collagen membrane in an eight-week rat calvarial defect
model. The combination of the bone graft and the membrane was aimed to simulate
clinical dental procedures for regenerating/restoring alveolar bone. In this study, the 8
mm calvarial defects were filled with Bio-Oss(R) (Geistlich, US), a widely used
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commercial bone graft material in dental procedures, and the defects were covered
with either a TEA/tBOC- or BA- modified membranes or a collagen membrane
(BioMend Extend (Zimmer-Biomet, Oakland). The regeneration of bone in the
defects was evaluated histologically and by microCT at 3 and 8 weeks. In addition to
the animal study, the surface morphology, residual TFA salts and endotoxin of the
membranes were evaluated.
Material and methods
Membrane preparation
Electrospinning of the chitosan membranes followed previously reported
procedures using a custom bench top set-up [8-10]. Briefly, a 5.50% (w/v) chitosan
[degree of deacetylation (DDA) = 71] in 70% (v/v) trifluoroacetic acid and 30% (v/v)
dichloromethane solution was electrospun at 26 kV onto a collector plate rotated at ~8
rpm to ensure random uniform distribution of spun fibers. For the TEA/tBOC treated
membrane, as-spun chitosan membranes were first immersed in 15% (v/v)
TEA/acetone solution for 48 hours and then rinsed in pure acetone for 3 times. Then
the membranes were soaked in an acetone solution containing 2 g/(550 mg chitosan)
di-tert-butyl decarbonate (Boc2O) for 48 hours, rinsed with acetone for three times
and dried in air. For the BA treatment, a 100 mg as-spun chitosan membrane was
immersed in a mixture of 10 ml of pyridine and 10 ml of butyryl anhydride for 1 hour,
washed 3 times in distilled water and dried by lyophilization [9].
The treated chitosan membranes were cut into disks (diameter = 14 mm) and then
sterilized using ethylene oxide gas (Anprolene AN 74j, Anderson Products, US). An
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additional 2 hours venting cycle after gas sterilization was applied for degassing
process. BioMend ExtendTM (Lot# CDMEN13M5), a commercially available collagen
GBR membrane was purchased from Zimmer-Biomet (Oakland, CA) and cut into 14
mm discs under aseptic conditions in a biological safety cabinet (1300 series, type A2
biological safety cabinet, ThermoFisher Scientific, Waltham, MA).
Membrane characterizations
Samples of prepared TEA/tBOC and BA- modified membranes were examined
by scanning electron microscopy (SEM) to verify the membrane nanofiber structure,
and energy dispersive spectroscopy (EDS) and 19F-NMR were used to verify removal
of TFA salts from the spun membranes [10]. Briefly, electrospun chitosan membranes
(n = 3) coated with 5 nm gold-palladium were observed for fiber morphology under
15 kV electron beam from 2500X to 5000X using an EVO HD15 (Carl Zeiss AG,
Germany) scanning electron microscope with EDS attachment (X-MaxN, Oxford
Instruments, UK). EDS spectra were collected and analyzed for presence of F atoms
from TFA salts using Aztec 3.0 software (Oxford Instruments, UK).
19

F NMR spectroscopy was used to evaluate and measure the amount of TFA salt

in the membranes (n = 3) before and after TEA/tBOC and BA treatments. 19F NMR
spectra were obtained using Varian 500 MHz (470 MHz for 19F) instrument with DClD2O (20% DCl) as a solvent. A solution of 1% (v/v) 2, 2, 2-triflurouethanol (TFE) in
the DCl-D2O solvent was used as an internal reference. A calibration curve was
prepared by using the integration ratios of TFA/TFE peaks of the standard solutions
containing known amount of TFA between 1 µl and 6 µl in 0.7 ml of 1% TFE/DCl-
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D2O solvent. The chitosan membranes were dissolved by cycling between 15 minutes
sonication and 15 minutes heating at 60 ˚C for 7 hours. The amount of residual TFA in
the membranes was calculated using the calibration curve.
Endotoxin
Triplicate specimens of each type of chitosan membrane were evaluated for
endotoxin using the Pierce LAL chromogenic endotoxin quantitation kit (Thermo
Scientific). Sterilized chitosan membrane disks (φ = 14mm) were placed in pyrogenfree water at the ratio of 1:100 (µg sample/µl water) and incubated with continuous
shaking for 24 hours at 50 ˚C [11]. The amount of endotoxin measured in the extracts
was normalized to mass. Bacterial endotoxin in the extracts catalyzed the activation of
a proenzyme in the modified Limulus Amebocyte Lysate (LAL). Then the activated
proenzyme catalyzed the splitting of p-Nitroailine (pNA) from the colorless substrate
that was proportional to the sample endotoxin concentration. A standard curve of
Escherichia coli endotoxin was used for calculating the sample endotoxin.
Animal Protocol
A rat critical sized (8 mm) calvarial defect model was used to evaluate
biocompatibility, degradability, barrier function and the ability of the TEA/tBOC
treated and BA treated membranes to support bone growth and healing as compared to
a commercial collagen membrane (Biomend Extend, lot# CDMEN13M5, Zimmer
Dental, US). The in vivo study protocol was reviewed and approved by the University
of Memphis IACUC committee (protocol #0732). In this study, 48 male Sprague
Dawley rats were used with one third of the animals treated with the TEA/tBOC
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treated chitosan membrane, one third with the BA treated membrane, and one third
with the collagen membranes.
For surgery, animals were first anaesthetized with 3% isoflurane/O2 gas via
mask. Then the surgical area was shaved and cleaned with betadine and 70% ethanol.
An incision around 20 mm was made along the midline over the calvarial skin from
the middle of the nasal bones to the posterior nuchal line. The underlying soft tissue
and periosteum were incised and pulled back to expose the calvaria. An 8 mm circular
defect was made in the center of the exposed calvaria using a custom trephine burr
and a dental drill with sterile saline irrigation to limit heating. After the cranium disk
was carefully dissected, 50 mg bone graft (Geistlich Bio-Oss, Geistlich) was used to
fill the defect, and then one TEA/tBOC treated chitosan membrane, BA treated
membrane, or a commercial collagen membrane was randomly selected to cover the
defect. Then the soft tissue and periosteum were repositioned and sutured over the
defect using a stainless-steel wound stapler (3M PreciseTM multi-shot disposable skin
stapler, 3M Precise). Half of the animals in each group were euthanized by CO2
inhalation at 3 weeks and the other half at 8 weeks post-implantation.
Tissue processing, microCT and histologic evaluation
After euthanasia, the defect site and surrounding bone were carefully dissected
and placed in 10% formalin, and the formalin solution was completely refreshed
every 24 hours for 3 days. After fixing, all specimens were scanned at 15 μm on a
Scanco μCT40 scanner (Scanco Medical, Bassersdorf, Switzerland). Images were
reconstructed and analyzed for percent bone fill and bone density using Scanco
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microCT evaluation program V6.5.1. Samples were then decalcified with
hydrochloric acid/ formic acid bone decalcifier (IMEB Inc., US) for 72 hours and cut
in the sagittal direction. The sections were stained by hematoxylin and eosin (H&E)
stain. All the histologic slides were evaluated by a pathologist blinded to the type of
GBR implant and scored for inflammation using a weighted rating scale as described
by Woodward [12]. Briefly, the reaction thickness was measured and graded from a
blinded examiner (KMA) on a 1 to 5 scale based upon the zone of reaction (from less
than 50 µm to greater than 2000 µm) around each grafted site. Within the reaction
zone, cellular response was graded from 0 to 5 depending upon the concentration of
cells. Cell types assigned values for the presence of neutrophils (value 5), giant cells
(2), macrophages (1), fibroblasts (1), and/or lymphocytes (1). The inflammation score
was subsequently calculated using these values and the following equation:
Inflammation score = (5 × reaction thickness) + (3 × cellular response) + [5 × (each
value provided for cells present)].
Numbers calculated through the above function represented the inflammation
extent according to the following standards: 0 represented no reaction; 1 to 10
represented minimal reaction; 11 to 25 represented slight reaction; 26 to 40
represented moderate reaction; 41 to 60 represented marked reaction; 60+ represented
extreme reaction.
Histologic slides were observed by Nikon Eclipse TE300 and montages were
created using Bioquant Osteo II software (Bioquant Image Analysis Corporation).
Two-way ANOVA was used for the statistical analysis of histomorphometry
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measurements and microCT data on bone growth rate, bone density, etc. with time
points as one-factor and membrane types as another. Tukey honest significant
difference tests was used for the post statistic evaluation. Statistical significance was
set at α = 0.05.
Results
Membrane characterizations
SEM images of the TEA/tBOC and BA treated membranes are shown in Figure 1.
Both membranes exhibited fibrous structure and the fibrous diameters were in the
nanoscale after the post-electrospinning treatments. The fiber diameter of the
TEA/tBOC treated membrane was 231.2 ± 93.3 nm and the diameter of BA treated
membrane was 283.9 ± 158.3 nm.
The results from EDS analysis were shown in Figure 2. Spectra were examined
for presence/absence of fluorine as an indicator of residual TFA salts. In the spectra, it
was not possible to observe a peak around 0.7 keV position for fluorine in the treated
membranes.
19

F NMR spectra were shown in Figure 3. The TFA salt peak at -77.66 ppm was

scarcely above background in both chitosan membranes. Using the calibration curve
and the mass of the membranes, both membranes showed less than 0.01% fluorine in
the membranes. There was no significant peak showed the existence of fluorine,
proved that all the fluorine has almost been removed completely.
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Figure 1. The SEM graphs of chitosan membranes (5000X). a) TEA/tBOC treated
chitosan membrane; b) BA treated membrane. Both membranes exhibited nanofibrous structure.

Figure 2. EDS spectra of a) TEA/tBOC treated chitosan membrane and b) BA treated
membrane.
The F peak was not detected in the both spectra of chitosan membranes indicating
removal of the TFA salts.
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Figure 3. 19F NMR spectra of chitosan treated membranes. a) TEA/tBOC treated
chitosan membrane; b) BA treated membrane.
Endotoxin
The endotoxin level of the BA treated membrane was 0.19 ± 0.03 EU/ml of the
extract solution. The level of the TEA/tBOC treated membrane was 0.07 ± 0.02
EU/ml. Normalizing to mass, endotoxin level of the BA treated membrane was 19.73
± 3.12 EU/g of the membrane, and the level of the TEA/tBOC treated membrane was
7.38 ± 1.51 EU/g.
Histologic analysis
The inflammation score showed that all rats had marked inflammation at week 3.
At week 8, the inflammation was reduced to moderate (Figure 4). Statistical analysis
showed that the scores at week 3 were significantly higher than week 8. However,
there was no significant difference in between membrane types.
Representative histologic sections showed initial woven bone formation superior
to the cutting edge at 3 weeks in all three groups (Figure 5). At 8 weeks, there was
increased lamellar maturation extending from the cutting edge into the defect area.
51

Bone graft materials were seen at both 3 and 8 weeks. New bone growth extending
from the bone graft was observed in some slides at 8 weeks (Figure 5(c2)). New bone
growth along the membrane could also be observed (Figure 5(c2)).

Figure 4. The Box and Whisker chart of Inflammation scores (n = 8/group).
× marked the mean points. Circles marked outlier points. Quantile was calculated
through the inclusive median.
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Figure 5. Composite histological micrographs and micro CT models of retrieved
specimen
with (b1) BA treated membrane at 3 weeks, (b2) BA treated membrane at 8 weeks,
(c1) TEA/tBOC treated membrane at 3 weeks, (c2) TEA/tBOC treated membrane at 8
weeks, (d1) collagen membrane at 3 weeks, and (d2) collagen membrane at 8 weeks.
(a) showed the representative structure of the histology slides. In the graph, triangles
point to the membrane, stars point to new bone, arrows point to the residue bone graft
pieces, and dash lines mark the defect cutting edge.
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MicroCT analysis
MicroCT results and analyses indicated there was no significant difference
between membrane types or time points for the bone volume in the defect area (Figure
6). If excluded one extreme out range value from each group, new growth bone
volume showed significant increase from 3 weeks to 8 weeks, but still no significant
difference between the membrane groups (data not shown). However, significantly
higher bone density was shown at 8 weeks than at 3 weeks (Figure 7). Further, both
treated chitosan membranes showed statistically significantly higher bone density
than the commercial collagen membrane (p<0.05).

Figure 6. MicroCT analyses of percent bone volume in the defect area.
Bars represent mean +/- stamdard deviation.
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Figure 7. MicroCT analyses of bone density results of the rat study at 3 weeks and 8
weeks.
Bars represent mean +/- stamdard deviation. Asterisk indicates significant difference
found in two-way anova compared to collagen membrane (p<0.05)
Discussion
The objective of this work was to evaluate the use of TEA/tBOC treated and BA
treated electrospun chitosan guided bone regeneration membranes to support/enhance
bone growth in rat critical sized calvarial defects treated with bone graft as compared
to a commercial collagen GBR membrane. These two methods aimed to keep the
fibrous structure of the electrospun chitosan membrane in aqueous conditions. SEM
graphs confirmed the fibrous structure in both TEA/tBOC- and BA- treated
membranes. These results were consistent with previous studies that the fiber
diameters were in the nano-scale range [9, 10]. It is noted that fiber diameters of the
BA treated chitosan membrane exhibited large standard deviation. The reason for this
is not clear. However, it is known that subtle variation in relative humidity,
temperature, operational details etc. do affect the electrospinning process [11-15]. The
laboratory bench top set-up used to manufacture the electrospun chitosan membranes
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used in this study operates under ambient conditions and hence, minor changes in
temperature, relative humidity could contribute to the increased variation in fiber
diameters as observed in some of the membranes. Additional standardization of the
spinning and post-spinning treatment conditions will be needed in the future to reduce
the variation.
TFA forms a salt with the amino groups on the chitosan molecule during the
electrospinning process. The TFA salt is extremely hydrophilic and leads to swelling
and loss of electrospun fibrous structure in aqueous environments. In addition, TFA is
toxic eliciting strong tissue reactions/irritations when exposed to skin, inhaled, or
ingested [16, 17]. Effectively eliminating the TFA salts was the key to keep the
fibrous structure and the biocompatibility of the chitosan membrane. EDS and 19F
NMR results demonstrated there was essentially no TFA salts left in the chitosan
membrane after both TEA/tBOC and BA treatments. In previous studies, TFA salt left
in the TEA/tBOC treated membrane was around 1%, and even at this level,
membranes showed good compatibility in vitro and in vivo [9, 10]. In this work,
residual TFA was reduced to less than 0.01% in both the TEA/tBOC and the BA
treated membranes, indicating these two methods could effectively remove the TFA
salts. The possible reason for the 100-fold decreased TFA salts concentration
compared to those observed in previous studies was attributed to using a longer
reaction time of 48 hours in the TEA solution and increasing rinses to 5 times during
the post treatment processes compared to the previous 24 hours and 3 times.
Endotoxin is a major component of the outer membrane of Gram-negative
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bacteria. Small amounts of endotoxin can activate the inflammatory response. Since
chitosan is derived from natural sources, it may be contaminated by microbial
pyrogens, especially endotoxin. Thus, the endotoxin level is important to understand
tissue responses to implanted chitosan medical devices. According to the FDA
guidance for pyrogen and endotoxin testing, recommended endotoxin limit is 0.5
EU/ml or 20 EU/device for products that directly or indirectly contact the
cardiovascular system and lymphatic system [18]. The endotoxin level of the
TEA/tBOC treated membranes used in this study was determined to be 0.07 ± 0.02
EU/ml or 7.38 ± 1.51 EU/g. For the BA treated membranes, endotoxin levels were
0.19 ± 0.03 EU/ml or 19.73 ± 3.12 EU/g. Since the 14 mm diameter post treated
chitosan membrane, which was used in this study, weighs approximately 0.005 to 0.01
g, both membranes used in this study exhibited endotoxin levels lower than the FDA
limits.
Overall, the tissue response followed typical inflammation and wound healing
processes. At 3 weeks, severe inflammation involving neutrophils, foreign body
granuloma, giant cells, lymphocytes and macrophages were generally observed at
implant sites and were associated with high inflammatory scores. This was considered
normal given that the initial inflammatory response would be large and in proportion
to the large 8 mm defect. It was noted that some samples exhibited reduced number of
neutrophils and hence less severe inflammatory scores, but this was not associated
with any particular implant material. At 8 weeks, tissue reactions involved
predominantly lymphocytes, macrophages and fibroblasts reflecting typical
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subsidence of inflammation and hence a decrease in inflammatory scores as expected
in a normal healing process.

It was noted that a few giant cells were observed

around the collagen membrane both at 3 and 8 weeks. However, there were quite a
few giant cells around chitosan membranes and bone graft material at 3 weeks and
then decreased to a few at 8 weeks. Overall the, the decrease in inflammation from
severe to more mild/moderate state was expected for a normal healing process for
these large defects.
The Woodward et al. inflammatory grading scale used in this work, uses a
weighted system based on several factors of the inflammation reaction, e.g. zone of
reaction, thickness of fibrosis and types of cells present, to assess degree of
inflammation [12]. In theory, by considering more inflammation aspects, the
evaluation results give an improved assessment of the overall tissue response. It is
noted that this rating scale heavily weighs the present of neutrophils, which may result
in more severe evaluation for some samples. By rescoring randomly picked samples
using the previous more qualitative 4-point system (0 = absent, 1 = mild, 2 =
moderate, and 3 = severe inflammation), some mild or moderate inflammation
samples evaluated by the 4-point system were scored as severe inflammation in the
Woodward scoring system [10]. However, most samples showed coincident results in
the two evaluating systems (data not shown). In the previous study, all membrane
types at both 3 and 12 weeks received mild or moderate inflammation scores of 2-3
using the 4-point system [9, 10]. Song et al. did a similar rat calvarial study of 8 mm
diameter defect with a commercial collagen membrane (Bio-Gide) and an
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experimental chitosan/fibroin-hydroxyapatite membrane [15]. They observed minimal
response at 2 weeks in both membrane groups. However, there was no description to
define the minimal, mild, moderate, and severe inflammation responses in their paper.
Baek et al. performed the same rat calvarial study as Song et al., and only mild
inflammation was observed at 8 weeks in the chitosan/fibroin-hydroxyapatite
membrane group [16]. Similarly though, Baek et al did not provide a clear description
of the inflammation evaluation system. It is noted that many studies using the calvaria
model to evaluate membranes do not provide detailed assessment of the inflammation
reaction or fail even to assess inflammation [17, 18, 19]. It seems that there is no
general inflammation evaluation standard of histology slides. Different rating scales
have different biases in evaluating the inflammation extent that may generate
confusion in comparing animal studies. In this study, the weighted rating system used
tended to score inflammation at a higher value indicating a more severe inflammation
at 3 weeks for all three groups as compared to previous studies. The severe
inflammation at 3 weeks might be caused by the surgical operation, poor control over
the irrigation, etc.
It was observed in several of the sections that the membranes had migrated away
from the calvarial defect. This may have occurred during closure of the defect using
the surgical staples that led to stretching and pinching of the skin over the defect.
Surgical staples were used in this procedure since it reduced the time the animals were
kept under anesthesia as compared to using sutures to close the wound. Exposure of
the defect due to membrane migration would not prevent the soft tissue intruding,
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which may have contributed to the severe inflammation responses in some sections.
From the histology slides, the samples that membranes did not fully covered the bone
defect area endured more severe inflammation (eg. scores of 72 and 77) as compared
to more moderate inflammatory responses and lower inflammatory scores (eg. scores
of 23 and 26) in specimen in which the defects remained fully covered by the
membrane. Though stapling did reduce the total surgical time, it may have resulted in
several membranes migrating away from the defect since the stapling tended to pull
the overlying tissue layers up and contributing to stronger inflammatory responses.
On the other hand, membranes that well covered the defect maintained effective
barrier function and bone regeneration support as intended. In the future, suturing
might be preferred method for securing the membrane and closing the tissue over the
implant area since that better helps the skin secure the implant over the defect area to
prevent migration. Since membrane migration in three samples was attributed to the
surgical process, they were excluded in subsequent microCT analysis.
Histological observations indicated that new bone growth was generally observed
to extend from the top of the defect edge and grow into the defect along the
membranes in a guided fashion [9,10]. Additional bone formation due to the
osteoconductivity of the Bio-Oss graft material also contributed to the overall bone
growth and filling of the defects. This is an expected way bone healing occurs in with
guided bone regeneration membranes [20]. The microCT analysis for percent new
bone showed that there was no difference in between either time points or membrane
types, which indicated that this study confirmed that chitosan membranes performed
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at a level similar to commercially available membranes. It is noted that in our
microCT analyses, we were not able to distinguish between the Bio-Oss® graft
material and the newly formed bone since both have similar mineral content which is
why there was no difference. While several groups have begun to develop algorithms
to distinguish bone graft from newly formed bone, these algorithms are not widely
available or easily implemented [21-23]. Song et al. used a commercial collagen
membrane (Bio-Gide) and an experimental chitosan/fibroin-hydroxyapatite membrane
to cover a non-grafted 8 mm diameter rat calvarial defect [15]. However, membrane
groups showed significantly greater amount of bone growth and bone density than
defects without a membrane at both time points, which suggested that membranes
helped bone growth and mineralization. According to Song’s microCT results, there
was around 3.7% new bone growth after 4 weeks and 5.2% new bone growth in
membrane groups after 8 weeks. Compared with our previous study, collagen
membranes (BioMend) showed 5% new bone growth after 3 weeks and 16% new
bone growth after 12 weeks, as well as TEA/tBOC treated chitosan membrane and BA
treated chitosan membrane [9, 10]. In this study, all membrane groups with Bio-Oss
had around 20% to 25% new bone growth after both 3 to 8 weeks according to the
microCT results, which suggested that Bio-Oss contributed to new bone growth. The
results of this study were consistent in having significant new bone increase after 8 or
12 weeks and no significant difference in between the membranes. Baek et al. did a
same non-grafted 8 mm diameter rat calvarial defect study with chitin-fibroinhydroxyapatite and Bio-Gide collagen membranes [16]. Their results were consistent
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with Song’s study. Lothi et al. did a non-grafted 6 mm diameter calvarial defect rabbit
study to compare bone regeneration between chitosan-collagen electrospun
membranes and Bio-Gide collagen membrane [24]. After 4 and 8 weeks, there was no
significant difference in the new bone formation between the two membrane groups,
or between different time points, which is consistent with this study Based on these
studies, it seems that new bone growth has a high variation in each rat group , which
may explain why we were not able to detect significant differences. Higher rat
numbers might be needed for each group to improve power to detect differences in
this measure with high variability.
Mineralization of the newly forming bone also increased significantly from 3 to 8
weeks as indicated by microCT bone density measurements for all groups. From the
histology slides, woven bone was observed in most of the new growth bone at 3
weeks and more lamellar bone was observed in most of the new formed bone at 8
weeks, which indicated that immature bone of lower bone density gradually turned to
mature bone of higher bone density from 3 to 8 weeks. This phenomenon was
coincident with the microCT results that the bone density was significantly increased
from 3 to 8 weeks. Both types of chitosan membrane had significantly higher bone
density than the samples with collagen membrane, indicating that chitosan
membranes were more effective in facilitating bone mineralization than the collagen
membrane. In our previous study, there was no significant difference either in the
bone density between the time points (3 weeks and 12 weeks) or among the
membrane types [9, 10]. Compared with this study, it suggested that the Bio-Oss bone
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graft helped tissue bone mineralization. Al-Askar et al. did a similar rat surgery with
the calvarial defect diameter of 4.6 mm [25], using Bio-Oss mixed with recombinant
human platelet derived growth factor to fill the defect. From 2 weeks to 10 weeks, the
new growth bone mineral density was significantly increased, and the remnant bone
mineral density was decreased. The result showed that the bone density of Bio-Oss
decreased rapidly after 10 weeks. Even at 6 weeks, the remnant bone density was far
from the original bone graft density. Another group examined in the study by AlAskar et al. used BioGide collagen membrane to cover the defect. From 2 weeks to 10
weeks, the new growth bone mineral density was also significantly increased and was
significantly higher than the density of no collagen membrane group, which suggested
that GBR membranes help improve the quality of the healing bone in the grafted sites
as compared to no GBR treatments. Compared to the results of this study, bone
density had significant increase at 8 weeks suggested that the new growth bone had
significant increase in bone density from 3 weeks to 8 weeks. Higher bone density
during the bone formation process has benefits of the earlier functional ability of the
bone tissue, and better new bone protection during the healing process. Hence, the
electrospun chitosan membranes showed better performance in increasing the bone
density than the BioMend collagen membrane, which suggested the superior aspect of
the nanofiber chitosan as a GBR membrane as compared to the more sponge like
structure of the collagen membrane.
Conclusion
An in vivo study was performed to evaluate the TEA/tBOC treated and BA
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treated chitosan membrane with statistic significant animal numbers. This study
showed coincidence results with the previous study and proved the stable property of
the TEA/tBOC treated and BA treated chitosan membranes. The surface morphology
confirmed nanofibrous structure and the removal of TFA salt residue. The endotoxin
level of membranes was under the FDA control limit. Improved mineral density
observed in these studies that improved mineral density observed in this study
indicated that chitosan membranes have advantages for use in clinical GBR
applications. Future evaluations may be needed to take the next step toward clinical
use.
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CHAPTER 4: A STUDY OF COMBINING ELASTIN IN THE CHITOSAN
ELECTROSPINNING TO INCREASE THE MECHANICAL STRENGTH
AND BIOACTIVITY
Abstract
While electrospun chitosan membranes modified to retain nanofibrous
morphology have shown promise for use in guided bone regeneration applications in
in vitro and in vivo studies, their mechanical tear strengths are lower than commercial
collagen membranes. Elastin, a natural component of the extracellular matrix is a
protein with extensive elastic property. This work examined the incorporation of
elastin into electrospun chitosan membranes to improve their mechanical tear
strengths and to further mimic the native extracellular composition for GBR
applications. In this work, hydrolyzed elastin from bone neck ligament (ES12, Elastin
Products Company, US) was added to chitosan spinning solution from 0 - 4 wt % of
chitosan. The chitosan-elastin (CE) membranes were examined for fiber morphology
using SEM, hydrophobicity using water contact angle measurements, mechanical tear
strength under simulated surgical tacking, and composition using Fourier transform
infrared spectroscopy (FTIR) and post-spinning protein extraction. In vitro
experiments were conducted to evaluate degradation in a lysozyme solution based on
mass loss and growth of fibroblastic and osteoblastic cells.
Chitosan membranes with elastin showed significant thicker fiber diameters,
lower water contact angles, up to 33% faster degradation rates and up to 7 times
higher mechanical strengths than the no elastin chitosan membrane. The FTIR spectra
presented that membranes with higher concentrated elastin had stronger peaks at 1535
cm-1 and 1655 cm-1, which were the peaks corresponding to elastin. Bicinchoninic
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acid (BCA) assay demonstrated a proportional protein concentration to the amount of
elastin added to the CE membranes. In addition, all the CE membranes showed in
vitro biocompatibility with both fibroblasts and osteoblasts.
Keywords: Electrospinning, chitosan, elastin, mechanical strength
Introduction
Guided bone regeneration (GBR) membranes are widely used to help
regenerating bone tissue in cranio-maxillofacial, periodontal, and implant treatments,
etc. [1]. In bone regeneration treatment, GBR membranes provided barrier function to
prevent premature bone graft resorption and increase amount of new bone
regeneration. Several studies and reviews highlight the effectiveness of GBR
membranes in regenerating bone [2-4]. GBR membranes are divided into nonabsorbable membranes and degradable membranes. Since non-absorbable membranes
requirea second surgery for extraction, degradable membranes are generally preferred.
Commercial degradable GBR membranes are made of collagen (BioMend Extend,
Bio-Gide) and poly-lactic acid (GUIDOR) etc. However, they have several
shortcomings, such as weak mechanical handling properties and unpredictable
degradation of collagen membranes. [5, 6].
Generally, GBR membranes are required to be biocompatible, biodegradable with
non-toxic degradation products, have proper mechanical strength, and be cell
occlusive to prevent invasion of soft tissues into graft sites, while allowing exchange
of nutrients and bioactive compounds between gingival and bone compartments [7].
Chitosan has attracted attention for use as a GBR membrane because it is non-toxic,
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biocompatible, biodegradable, and low cost. Electrospun chitosan membranes have
been explored to make GBR membranes with good biocompatibility, biodegradability,
support function for newly formed bone, and nanofiber-porous structure that mimics
the nanofiber structure of the native extracellular matrix that is also cell occlusive [810].
Mechanical tear strength is an important property in evaluating the membrane
handle-ability since membranes need to be strong enough to be manipulated and
secured in place during implantation operations [11]. Thicker GBR membranes with
stronger mechanical strength have been preferred for GBR treatments but may lead to
dehiscence of soft tissues and membrane exposure [11]. In our previous study, the tear
strength of electrospun chitosan membranes was similar to the BioMend Extend
collagen membrane. However, it was still weaker than the Bio-Gide collagen
membrane that was preferred by the dentists because of its strong handle-ability [1].
To increase the tear strength, elastin maybe incorporated into electrospun chitosan
membrane. Elastin is an extracellular protein that provides the elasticity of the tissues,
such as blood vessels, ligaments, lung, and skin [12]. Researchers have explored using
elastin in tissue engineered skin [13], vascular grafts [14], heart valves [15], and
cartilage [16] constructs. Collagen [17, 18], poly-lactic-co-glycolic acid (PLGA) [19,
20] and polycaprolactone (PCL) [21] etc. have been mixed with elastin to make
electrospun materials. A study from Chloe et al. showed that adding both insoluble
and soluble elastin increased the tensile strength of a collagen porous scaffold [22].
Soluble elastin resulted in increased tensile compared with insoluble elastin when
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added to collagen scaffolds [22]. In addition to its structure function, elastin can
accelerate tissue regeneration and induce the osteogenic response [12]. Solubilized
elastin has been reported to enhance the biocompatibility of synthetic materials [23,
24].
In this study, the effects of incorporating a hydrolyzed soluble elastin from bovine
neck ligament into electrospun chitosan membranes were examined. The role of
increasing elastin composition was explored through evaluations of physical and
chemical properties, surface morphology, water contact angle, Fourier transform
infrared spectroscopy (FTIR), elastin incorporation, degradation, tear strength, and
cell proliferation on CE membranes.
Materials and Methods
Membrane preparation
Electrospun membranes were prepared based on a previously described method
[1]. In brief, chitosan solution was prepared by dissolving 5.5% (w/v) chitosan (71%
DDA) in 7:3 (v/v) trifluoracetic acid/dichloromethane solution overnight. Before
electrospinning, elastin (ES12, Elastin Products Company, US) was added in the
chitosan solution at 0, 1%, 2% and 4% (w/v) of spinning solution. A 10 ml solution
was prepared for each chitosan membrane with 0 and 1% elastin, and a 5 ml solution
was prepared for each membrane with 2% and 4% elastin. A 10 ml syringe with an
18-gauge blunt needle was filled with the chitosan-elastin (CE) solution and then
place on a syringe pump set to 15 μl/min. An aluminum foil covered plate 15 cm
away from the 26-kV voltage needle tip was rotated to collect the electrospun
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nanofibers. Membranes were then subjected to post-spinning immersion in
triethylamine (TEA)/ di-tert-butyl decarbonate (tBOC) as previously described [7].
Briefly, membranes are immersed in 10% TEA/acetone for 48hrs to remove TFA salts
formed during the spinning process. Membranes were then submerged in 0.1g/ml
tBOC/acetone solution with stirring for 36hrs, followed by rinsing with acetone and
dried between two pieces of nylon mesh in air.
Surface morphology
The surface morphology of CE membranes was observed by scanning electron
microscopy (SEM) using an EVO HD15 (Carl Zeiss AG, Germany) scanning electron
microscope. CE membranes were adhered to an SEM stub and coated with 5 nm goldpalladium. Samples were observed from 2500x to 6500x. Fiber diameters were
calculated from 20 randomly selected fibers from each membrane using the SEM
image analysis software. Triplicate samples of each membrane type were evaluated.
Water contact angle
The hydrophobic/hydrophilic property of the CE membranes was evaluated by
the water contact angle. Contact angles of the water drop contacting the membrane
surface were recorded by the VCA optima measurement machine (AST products, US).
There was one drop per specimen and five samples of each membrane type were
tested.
Fourier transform infrared spectroscopy (FTIR)
FTIR was used for evaluating the elastin content in the CE membranes. FTIR
spectra were collected using a Nicolet 380 FTIR spectrometer (Thermo Electron
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Corporation, US). Three samples of each TEA/tBOC treated CE membrane were
scanned from 500 cm-1 to 4000 cm-1 32 times.
Bicinchoninic acid (BCA) assay
BCA assay was used for evaluating the elastin concentration in the CE
membranes. Each TEA treated CE membrane was cut into 4 mg pieces (n=3). These
samples were dissolved in a solution containing 0.014% (w/v) sodium deoxycholate
and 6.55% (w/v) trichloroacetic acid overnight. After centrifuging the solution at 5000
rpm for 15 minutes, the supernatant was carefully removed without disturbing the
bottom pellet. A 5% sodium dodecyl sulfate (SDS) solution was added to dissolve the
protein pellet. The sample solution was tested using the Pierce BCA Protein assay
(Thermo Scientific, US). A standard curve made from elastin solution was used for
calculating the protein concentration.
Degradation
The degradation of CE membranes was evaluated based on mass loss. Samples of
each CE membrane were cut into 3 cm2 squares (n = 3) for each time points of 1
week, 2 weeks and 4 weeks. After recording the original sample weight, samples were
soaked in phosphate buffered saline (PBS) solution containing 100 μg/ml lysozyme,
500 I.U./ml penicillin, 500 μg/ml streptomycin, and 25 μg/ml Amphotericin-B at 37
˚C. The solution was changed every 2 days. At 1, 2, and 4-week time points,
membranes were retrieved, rinsed in DI water, dried for 48 hours and weighed (mg) to
record the change in mass. Compared with the lysozyme level in human plasma,
which is 3 - 8 μg/ml, high level was used in the experiment to accelerate degradation
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and magnify potential differences over the course of the experiment.
Mechanical strength
A mock surgical tack test was used to evaluate the mechanical tear properties of
the TEA/tBOC treated CE membranes, as an indicator of clinical handle-ability.
Specimens of 10×30 mm were tacked to a 7.5×7.5×0.5 cm white oak board as a bone
analogue [1], using the AutoTac system kit, (Biohorizons, Birmingham, AL, USA). A
point 5 mm from the wide top and 5 mm from the length edge of the specimens were
used for tacking membranes to the wood board. The wood was positioned in the lower
clamp of an InstronTM Model 4456 mechanical test frame, and the free end of the
membrane was positioned in the upper clamp. The load cell used was 50 N and the
extension rate was 1 mm/min. Maximum load was recorded in Newton (N) and then
normalized to membrane thickness. The stretching lengths were recorded in
millimeter (mm) and then normalized to original length. Triplicate samples of each
type of membrane were tested.
In vitro cell proliferation
Ethylene oxide gas sterilized disc-shaped chitosan membrane specimens
(diameter = 1.5 cm) were inserted in 24 well plates for the evaluation of osteoblast
and fibroblast growth on the membranes for 7 days. Membranes were rinsed in culture
media overnight and then seeded with MC 3T3 or NIH 3T3 cells (ATCC, Manassas,
VA, USA) at 5×104 cells/well. Cells were grown in MEM-α medium mixed with 10%
FBS and 500 I.U. /mL penicillin, 500 μg/ml streptomycin, and 25 μg/ml
amphotericin-B. Cell growth was measured using the Cell Titer GloTM luminescent
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cell viability assay (Promega, Madison, WI, USA). The assay was based on luciferin
luciferase reaction to measure the amount of ATP, which was proportional to cell
numbers (n = 4/sample per day per cell type). Data was reported in relative
luminescent units (rlu).
Statistical analysis
One-way analysis of variance (ANOVA) at the 0.05 level of significance was
used for analyzing the results of fiber diameter, water contact angle, protein
concentration and mechanical strength with membrane types as the factor. Two-way
ANOVA at the 0.05 level was used for analyzing the degradation and cell proliferation
results using membrane types as one factor and time points as another. Tukey’s posthoc tests were used to distinguish significantly different groups.
Results and Discussion
Surface morphology
CE membranes showed that they have well preserved nanofibrous structure in the
SEM graphs (Figure 1). Fiber diameters increased with increasing percent of elastin
(Table 1). The fiber diameter of the no elastin and 1% CE membrane were
significantly smaller than the 2% and 4% CE membranes, and the diameter of the 4%
elastin CE membrane was significantly larger than the 0% and 1% elastin CE
membranes but not different from the 2% CE membrane (p = 10-4).
The no elastin nanofibers in this work exhibited fibers diameters on par with the
previous study, which was 330 ± 130 nm [1]. The differences in the mean values
between the two studies are likely related to the seasonal differences in moisture and
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temperature at the time of spinning since the spinning procedure is done at ambient
atmospheric conditions and changes in temperature and humidity are known to have
significant effects on size of electrospun fibers [25, 26]. Even though there was some
variability in fiber diameters between studies, overall, the electrospinning process
produced fibers in the nano-scale range which was considered an advantage for
mimicking the native ECM fiber network.
Other research groups have electrospun elastin either by itself or when combined
with collagen. Elastin fibers have been electrospun with diameters between 1 μm to
500 nm, depending on spinning conditions [27, 28]. When combined with collagen,
electrospun fibers with diameters between 490 nm to 800 nm have been made [27,
28]. It is interesting to note though that the diameters of the collagen-elastin
composites were typically larger than their pure collagen control counter parts
suggesting that elastin tends to increase fiber diameters. This may be due to the noncrystalline network structure of the elastin protein [27, 28]. Similar effects of
increasing fiber size with increasing additions of elastin to the electrospun chitosan
fibers were observed in this work.
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Figure 1. The SEM graphs of the a) 0% elastin CE membrane, b) 1% elastin CE
membrane, c) 2% elastin CE membrane and d) 4% elastin CE membrane with the
6500X magnification.
Fibrous structure could be observed in all the CE membranes.
Table 1. The fiber diameter and water contact angle of CE membranes.
CE membrane
0% elastin
1% elastin
2% elastin
4% elastin
type
Fiber diameter
158.7 ±46.3a 214.9 ±95.8b
243.9 ±62.5b
308.4 ±97.8c
(nm)
Water contact
127.6 ±7.8ϕ
113.7 ±2.2&
109.9 ±2.9&
110.6 ±3.9&
angle (degree)
Note: super scripts were used to indicate statistical difference (α = 0.05) between the
membrane types. a and b indicated the significant difference of fiber diameters from
the 1% and 2% groups. ϕ and & denoted the significant difference of water contact
angle from other three groups.
Water contact angle
The hydrophobic/hydrophilic properties of the CE membranes were tested by the
water contact angle. Chitosan membranes with 1 to 4 (w/v) % elastin all had
significantly reduced the water contact angles as compared to the 0% elastin control
(Table 1). However, the water contact angles for all membranes were greater than
100° indicating that the membranes still exhibited highly hydrophobic characteristics.
Compared with the previous study, the water contact angle of the no elastin membrane
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was 119.4 ± 14°, which was coincident with the result here [1]. The addition of elastin
protein to the spinning solution decreased the hydrophobic characteristic of the
electrospun membranes. This increase in hydrophilicity is reasonable because the
ES12 elastin is water-soluble. However, because the tBOC modification results in
three methyl groups being attached to the surface of the fibers, the membranes
remained largely hydrophobic.
FTIR
The FTIR spectra of the CE membranes and elastin powder are shown in the
Figure 2. In the spectra, two main peaks at 1535 cm-1 and 1655 cm-1 corresponded to
the amide II and amide I bands of the elastin respectively [29]. The amide I and II
peaks of the elastin are observed in the CE electrospun membranes and peak
intensities increase with increasing elastin incorporation due to increasing elastin in
the spinning solution.
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Figure 2. The FTIR spectra of the pure elastin powders and the CE membranes.
The peaks at 1535 cm-1 and 1655 cm-1 corresponded to the elastin amide band II and
amide band I (black arrow indicated positions). From the top to the bottom at the two
peaks position, the curves represented the (a) 0% elastin CE membrane, (b) 1% elastin
CE membrane, (c) 2% elastin CE membrane, (d) 4% elastin CE membrane and (e) the
elastin powders respectively.
Bicinchoninic acid (BCA) assay
The results of the protein assay to determine the amount of elastin incorporated
into the electrospun fibers is shown in Figure 3. Membranes subjected only to TEA
(no tBOC reaction) were examined to see if the TEA/tBOC reaction process resulted
in any loss of elastin from the membranes. In addition, the acetone wash solutions
were also evaluated for any extracted elastin protein. Results showed that there was a
significant increase in the measured protein content of the fibers with increasing
percent elastin. It was further noted that there was no difference in the amount of
protein measured in the TEA or TEA/tBOC treated samples indicating that the tBOC
treatment did not result in a significant loss in elastin protein from the electrospun
fibers during reaction. The low protein content of the TEA washing solution further
confirmed that the TEA/tBOC treatments were not extracting or washing out the
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elastin from the electrospun fibers.
While there was a proportional increase in total protein in fibers with increasing
elastin additions to the spinning solution, the total protein measured was
approximately 1/6th of the theoretical amount based on the original chitosan-elastin
spinning solution mixture. However, the BCA assay may not have accurately
measured the amount of elastin extracted from the electrospun fibers due to
interference of chitosan with the assay. To verify the interference, the pure elastin
powders and chitosan-elastin powders mixed at the same weight ratios as used in the
spinning process and tested using the BCA assay kit. The result showed that the BCA
assay identified almost all the pure elastin powders but only identified around onefifth of the elastin in the elastin-chitosan mixtures (data not shown). Hence, the BCA
assay is likely underestimating the amount of elastin in the fibers. In addition, it is
also possible that the TFA might have degraded some elastin during the
electrospinning process. Further study will be needed to determine the amount of
elastin in the fibers and or if the TFA is causing degradation of the elastin protein.
Nevertheless, the data due correlate qualitatively with the FTIR data that increasing
amounts of elastin are being incorporated into the membranes with increasing
additions of elastin to the spinning solution.
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Figure 3. BCA assay result of the TEA treated CE membranes, TEA/tBOC treated CE
membranes, and TEA washing solutions during the TEA treatment.
The protein ratio significantly increased with the increased elastin concentrated CE
membranes. There was no significant difference in between the two procedures
treated CE membranes. The protein ratios of TEA washing solutions were extremely
lower than the 1%, 2%, and 4% elastin CE membranes. +, × and § denoted the
significant difference from the other groups. Bars represent mean +/- stamdard
deviation.
Degradation
The degradation results showed that the 1%, 2% and 4% elastin CE membranes
had higher degradation rate than the no elastin chitosan membrane. After 4 weeks, no
elastin chitosan membrane had significant higher residual mass than the other CE
membranes (Figure 4). The 4% elastin CE membrane had significantly higher residual
mass than the 1% and 2% CE membranes and significant lower residual mass than the
no elastin chitosan membrane. The weight of all the membranes was significantly
reduced over time from the initial week to 4 weeks.
All the membranes showed significant degradation after 4 weeks proved that the
CE membranes were degradable. In a previous study, the no elastin chitosan
membrane had significantly decrease in membrane weight after each time point [1].
After 1 week, 2 weeks, and 4 weeks, the membrane residue was 89.4 ± 6%, 65.6 ±
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3.9%, and 56.4 ± 2.3% respectively in the previous study. Compared with this study,
the no elastin chitosan membrane had 71.7 ± 4.6%, 65.7 ± 2.9%, and 58.4 ± 1.1%
residual mass after 1, 2 and 4 weeks respectively, which was consistent with our
previous work [1]. After combining the elastin in the chitosan electrospun
membranes, the degradation rate become higher than the no elastin membrane , which
might be due to

elastin causing a disruption in the chitosan crystalline structure

making the amorphous polymer more susceptible to degradation. The lysozyme
concentration was very high and so these in vitro tests were not necessarily predictive
of how membranes might degrade in vivo or whether they would meet the 4 to 6
months maintenance to provide the osteo-regeneration protection. The increase in
degradation needs to be balanced with the need to provide barrier function for the 4 to
6 months [1]. If faster healing of tissue occurs with CE membranes, faster degradation
may not be an issue. Further studies evaluating degradation in vivo over these
clinically relevant time frames are needed to confirm these properties.
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Figure 4. Degradation results of the CE membranes. Bars represent mean +/stamdard deviation.
Mechanical strength
The result of the surgical tac test showed increased tearing strength with the
increased elastin concentration. The tear strengths of the 0% to 4% elastin CE
membranes increased from 25.8 ± 8.5 N/mm, to 54.3 ± 7.9 N/mm, 91.2 ± 29.3 N/mm
and 195 ± 41.3 N/mm, respectively (Figure 5a). There were significant differences in
between the no elastin membrane, 2% elastin membrane, and 4% elastin CE
membranes. The total elongation of the 0% to 4% CE membranes were 4.4 ± 0.6 %,
8.0 ± 1.1 %, 5.1 ± 2.1 % and 8.3 ± 2.1 %, respectively (Figure 5b). The stretching
lengths of the 0% and 2% elastin CE membrane groups were significantly shorter than
the 1% and 4% elastin CE membrane groups.
Adding elastin in the electrospun chitosan membranes greatly improved the
tensile properties over that of the plain electrospun chitosan membranes. The
mechanical tear strengths of the 2% and 4% elastin CE membranes were similar to or
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greater than tear strengths of two commercial collagen membranes (Bio-Gide 133.9 ±
21.5 N/mm; BioMend Extend 55.3 ± 7.5 N/mm) tested under similar conditions. It is
noted too that these CE membranes are thinner than the commercial collagen
membranes. The ability to achieve similar tear strengths with thinner membranes may
be an advantage for handling and implanting in sites where gingival tissues may be
thin, as well as providing improved protection to underlying bone graft materials. In
addition, percent elongation of the CE membranes was generally increased over that
of the no elastin membranes. This coupled with the increased tear strength would
indicate that elastin addition increased the toughness of the CE membranes. The
highly elastic protein of elastin increases the stretching and contracting capability and
hence increases the tearing strength of the CE membranes. Though the elongation was
not in proportion to the elastin concentration as expected, this might be an artefact of
spinning membranes from a smaller solution and having thinner membranes. But the
effect of increasing from 2 to 4 % was clear on increasing stretching length.
The tear strength of the no elastin membrane in this study was approximately
50% lower that the tear strength of TEA/tBOC modified membranes previously
reported. [1]. This difference is attributed to the differences in that in the previous
study, a 30 ml chitosan solution was used to prepare the electrospun chitosan
membranes as compared on only 10 ml chitosan solution used in this study. The
chitosan membrane made from 30 ml solution (thickness = 0.15 mm) was thicker than
the membrane made from 10 ml solution (thickness = 0.1 mm). From the rough
evaluation, triple volume solution and the more compact structure of the membrane in
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the previous study than the membrane in this study, which was reasonable to explain
the higher tear strength of the no elastin membrane in the previous study.

Figure 5. (a) Surgical tear strength and (b) stretching lengths of the CE membranes.
Maximum load was recorded in Newton (N) and then normalized to membrane
thickness.
Bars represent mean +/- stamdard deviation. *, + and × denoted the significant
difference from the 1% elastin CE membrane. # denoted the significant difference
from the 1% and 4% elastin CE membranes.
In vitro cell proliferation
The cell proliferation results were shown in the Figure 6 and Figure 7. The NIH
3T3 fibroblast cells showed significant proliferation after 4 days and 7 days on all the
CE membranes (Figure 6). Among the four types of the CE membranes, the 1% and
2% elastin membranes were significantly lower with the other membranes. After 7
days, the MC 3T3 bone cells showed significant proliferation on the all CE
membranes (Figure 7). There was no significant difference in between the membrane
types.
In this study, both fibroblasts and osteoblasts showed significant proliferation
after 7 days, suggesting the in vitro biocompatibility of the CE membranes. In a
previous study, the no elastin membrane showed significant cell proliferation with the
Saos-2 osteoblasts after 5 days [1]. Besides, a pilot rat study (data not shown) was
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performed with the no elastin chitosan membrane, which showed significant new
bone growth after 12 weeks.

Figure 6. Graph shows mean RLU of the NIH 3T3 cell proliferation on the CE
membranes. There was significant difference in between the time points.
*, + and ◊ denoted the significant difference of each time points. The cell proliferation
on the 1% and 2% elastin membranes was significantly different with all the other CE
membranes. § and & denoted the significant difference from the 0% and 4% elastin
CE membrane groups. Bars represent mean +/- stamdard deviation.
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Figure 7. The graph of the MC 3T3 cell proliferation on the CE membranes.
There was significant difference in between the time points. * and + denoted the
significant difference of time points. There was no significant difference in between
the membrane types. Bars represent mean +/- stamdard deviation.
Conclusion
This study obtained the preliminary results of the chitosan-elastin electrospinning
in order to increase the mechanical properties. The chitosan membranes with elastin
exhibited thicker fiber diameters, lower water contact angles, higher degradation rates
and higher mechanical strengths than the no elastin chitosan membrane. The FTIR
spectra and the protein concentration test both proved that CE membranes with more
elastin amount showed higher elastin/protein concentrations which lead to increased
tear strengths and toughness of the membranes. Besides, both no elastin chitosan
membranes and chitosan membranes with elastin showed in vitro biocompatibility
with both fibroblasts and osteoblasts. In conclusion, this study has proved that adding
elastin in the chitosan electrospinning could effectively increase the tear strength of
the membranes that might be useful for increasing the clinical handle ability of
suturing the GBR membrane to the soft tissue.
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CHAPTER 5: CONCLUSION
This study was focused on performing additional material characterizations and
in vitro and in vivo evaluation of the electrospun chitosan membranes treated by novel
post-spinning treatment methods. In addition, improvement of the mechanical
properties was explored by adding elastin to the electrospun chitosan membrane
composition to increase the membrane mechanical tensile strength and handle-ability.
In the previous study, chitosan was successfully electrospun and kept the
nanofibrous structure in the aqueous environment [37]. Initial in vitro and in vivo
evaluations of both the TEA/tBOC treated and BA treated chitosan membranes
proved that both membranes were biocompatible, biodegradable, and had adequate
mechanical strength.
Following the previous studies, this study has first evaluated the TEA/tBOC
treated electrospun chitosan membrane with the Na2CO3 treated electrospun chitosan
membrane as compared to simple chitosan films. The aim of this study was to
determine the importance of maintaining the nanofiber structure of the membranes for
promoting cell growth and mineralization as compared to membranes with no fibrous
structure. The results showed that the TEA/tBOC treated chitosan membrane kept the
nanofibrous structure as compared to a typical alkali treated electrospun chitosan
membrane and exhibited significantly greater porosity. Porosity is considered an
important factor for GBR membranes to allow for exchange of signals and nutrients
between bone and soft tissue compartments for improved bone regeneration. The
TEA/tBOC treated membranes showed better cell mineralization in the dual cell
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culture model which demonstrated that the nanofibrous structure with increased
porosity was beneficial for nutrition exchange and promoting mineralization as
compared to other membranes much reduced or no porosity. The tBOC group of the
TEA/tBOC treated chitosan membrane hydrolyzed slowly at 37 ˚C and 70 ˚C in a 21day test. Higher temperatures promoted faster tBOC group degradation speed. The
endotoxin levels of all kind membranes were under the required limitation, which
indicated that the membranes were free of bacterial contaminants and hence would
not elicit the unintended tissue response. Cell proliferation showed that all three
membranes had the similar osteoblast and fibroblast proliferation ratio, which was
coincident with the previous results [37].
Based on the conclusion that the electrospun chitosan membranes with the
nanofibrous structure showed better cell mineralization property than the
membrane/film with no porous structure, the TEA/tBOC treated chitosan membrane
and another BA treated chitosan membrane, which also had nanofibrous structure,
were further evaluated using the in vivo rodent calvarial defect model with bone graft.
Both the chitosan membranes showed the nano fibrous structure and the endotoxin
concentrations that were under the FDA required limitation. A rat calvarial study with
the two-method treated chitosan membranes and the commercial collagen membrane
showed that all membranes supported bone growth after both 3 and 8 weeks. New
growth bone with the chitosan membranes showed significant higher bone density
than the new growth bone with the collagen membrane and indicated that the chitosan
membranes might promote more bone mineralization than the collagen membranes.
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This was consistent with the previous conclusion that the chitosan membrane with the
fibrous structure helped cell mineralization. The inflammation scores of the histology
slides showed significant decrease from 3 weeks to 8 weeks. The representative slides
showed that initial woven bone formation superior to the cutting edge at 3 weeks in
all membrane groups.
Though electrospun chitosan membranes have shown advantages in helping
tissue regeneration, the relatively low mechanical strength was another concern. In
order to increase the mechanical strength, elastin was added in the chitosan solution to
increase the elastic property of electrospun chitosan membranes and, hence increasing
the mechanical strength. Four ratios of the elastin powders were added to the chitosan
solution before the electrospinning in preparing the EC membranes. The EC
membranes of all ratios exhibited thicker fiber diameter than the fiber diameter of the
no elastin chitosan membrane. The water contact angles of the CE membranes were
less than the no elastin chitosan membrane indicated that the CE membrane surface
was more hydrophilic than the no elastin chitosan membrane. As expected, the
surgical tacking strength of the chitosan-elastin membranes significantly increased
with the increased elastin ratio, as well as increased stretching length. Membrane
thickness was another factor that affected the tensile strength and the stretching
length. The degradation rate of the chitosan-elastin membranes was higher than the no
elastin chitosan membrane. Further study will be needed to evaluate whether the
decreased membrane stability over time would allow for membrane retention over the
tissue healing time frame. All membranes showed both fibroblasts and osteoblast cell
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compatibility, which proved that both chitosan membrane and elastin were
biocompatible.
In conclusion, the TEA/tBOC treated chitosan membrane was more effective in
helping cell mineralization than the non-porous structured membrane/film. Both
TEA/tBOC treated and BA treated chitosan membrane showed more efficacy in
promoting bone mineralization in the rat calvarial study than the commercial collagen
membrane. The mechanical strength of the electrospun chitosan membrane could be
effectively increased by adding elastin.
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CHAPTER 6: FUTURE WORK
Though this dissertation has achieved some progress in evaluating and improving
the chitosan GBR membranes, more future work will be needed.
Only cell proliferation, ALP activity and calcium deposition were evaluated on
the electrospun chitosan membranes. In this work, a co-culture model was used to
better simulate the clinical situation of the membrane separating the fibrous gingival
tissues from the osseous tissues. This model could be optimized so that membrane
grew fibroblasts on one side and osteoblasts on the other side instead using a transwell
model. Having the cells grow directly on different sides of the membrane may be
better because it would allow more direct interaction between the two cell types.
Besides, more detailed cell performance evaluations were needed, such as the
quantification of calcium-phosphate deposition at different time points. Other factors
could also be examined include elobration of collagen, osteocalcin, and other matrix
proteins as indicators of enhanced tissue development.
Rat calvaria studies were used in this study to test the in vivo performance of the
chitosan membranes. Other models of different animals or larger sizes will be needed
in the process of the commercialization. According to the FDA medical device safety
requirements, larger animals, such as pigs, sheep and dogs, and longer time frame
animal tests will be needed [9]. These larger animal models would allow for the
evaluation of the membranes in a mandibular and or maxillary bone defect model that
reflects the most common clinical applications of these GBR type membranes.
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Though the elastin used in this study showed effective mechanical improvement
in the chitosan elastin membranes, it might be more costly to manufacture compared
with other synthetic and naturally derived membranes. More economic substitute
elastin products with the similar properties should be explored. Besides, in vivo study
will be needed for testing the in vivo compatibility of chitosan elastin membranes.
The in vitro degradation test has proved that electrospun chitosan membranes
were degradable. However, whether they could meet the clinical healing time frame is
unknown. The in vivo degradation ratio needs to be evaluated by 16 to 24 weeks
animal studies. The in vitro study of the elastin chitosan membrane has proved that
adding elastin could increase the degradation rate. Hence, if the degradation ratio was
too low, adding materials such as elastin, or lowering the DDA of the chitosan, or
using lower molecular weight chitosans could be used for increasing the degradation
ratio. But if the degradation ratio was too fast to meet the 4 to 6 months healing
frame, crosslinking of the membrane or adding higher DDA chitosan in the
electrospun solution could be used for decreasing the degradation ratio.
Considering that different growth environment requirements of osteoblasts and
fibroblasts, membranes could be designed and produced in which the top and bottom
of the membranes had different structures and or properties. The top side or surface
could be designed to better interface with the gingival soft tissues and bottom side or
surface designed to better interface with the healing osseous tissues. The specific
design pointed to the individual cell type aimed to facilitate faster healing. In vitro
dual cell culture study could be used for verifying the cell performance.
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